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Abstract 
Cardiovascular prostheses are routinely used in surgical procedures to address congenital 
malformations, for example establishing a pathway from the right ventricle to the pulmonary 
arteries (RV-PA) in pulmonary atresia and truncus arteriosus. Currently available options 
including homograft (human donor) and xenograft (animal products) have limited 
biocompatibility and durability, and their fixed size necessitates multiple subsequent re-
operations to upsize the conduit to match the patients’ growth and address structural 
deterioration of the valved conduit. Moreover, the pre-set shape of these implants increases the 
complexity of operation to accommodate patient specific anatomy. The ultimate goal of the 
research group is to address these limitations by 3D printing geometrically customised implants 
with growth capacity.  
This study addresses design aspects of this goal with material science aspects being addressed 
by other researchers. It is sought to integrate tissue engineering techniques with modern 
medical imaging and image processing tools, together with mathematical modelling. In this 
study, patient-specific geometrical models of the heart were constructed by performing 
segmentation on MRI data of patients using Mimics inPrint 2.0. Segmentation is a method of 
constructing the shape of the region of interest by defining its boundaries. Computational Fluid 
Dynamics (CFD) analysis was performed, using ANSYS CFX, to design customised 
geometries with better haemodynamic performance. Material design was also modified by 
feedback from computational modelling, using ANSYS Mechanical, of various material 
characteristics. 
CFD simulations showed that customisation of a replacement RV-PA conduit can improve the 
haemodynamic performance of the implant, which may reduce right ventricular work and 
improve durability by minimising biomechanical stresses. For example, it was demonstrated in 
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this study that the mechanical energy dissipation and wall shear stress can be significantly 
reduced by optimising design. Finite Element modelling also allowed prediction of the 
optimised thickness of a synthetic material to replicate the behaviour of pulmonary artery wall 
under arterial pressures. This has helped by eliminating potentially costly and time-consuming 
experiments, largely based on trial-and-error, with as much work done in silico as possible. 
In conclusion, we have demonstrated that patient-specific design is feasible and that derived 
designs are likely to improve the flow dynamics of the novel RV-PA connection. Modelling 
also provides information relevant to optimisation of the novel biomaterial. In time, 3D printing 
a customised implant may simplify replacement procedures and potentially reduce the number 
of operations required over a life time, bringing substantial improvements in quality of life to 
patients with RV-PA conduits.   
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1.1 Background 
Congenital heart disease (CHD) is an abnormality affecting the structure of the heart that is 
present at birth. Defects can involve formation of the cardiac chambers themselves, the inflow 
or outflow valves, or the arteries and the veins that carry the blood to and from the heart and 
lungs. CHD is the most common congenital disorder in newborns with a prevalence of 
approximately 1% of live births [1]. About 25% of babies with CHD have a critical condition 
requiring surgery or other invasive procedures in their first year of life [2]. Of particular 
relevance to our study are the CHD subtypes pulmonary atresia with ventricular septal defect 
(PA/VSD) and truncus arteriosus (TA). For both conditions, procedures are required to restore 
continuity between right ventricle and pulmonary artery (RV-PA), usually involving placement 
of a valved conduit. 
The conduit procedure normally takes place early in the first year of life, hence, children 
outgrow the implanted conduit and require replacement of the conduit later in life. Although 
the mortality rate has decreased significantly as a result of developments in clinical practice 
and technical performance, there are still long-term physiological and economic impacts on the 
children with these conditions [3, 4]. Imperfect haemodynamic conditions, with a common 
transition involving valve competence to valve incompetence and progressive narrowing of the 
conduit are well tolerated by the right ventricle for a long period of time. Adaptations include 
right ventricular hypertrophy and/or dilatation. To address this, replacement of the valved 
conduit is required, involving several further open-heart operations or other invasive 
interventions, such as catheter-based procedures. 
The ideal RV-PA valved conduit implant should have close to normal haemodynamic 
characteristics, resistance to thrombosis, durability and freedom from structural valve 
deterioration (SVD), and above all, an ability to grow in proportion to the patient’s somatic 
growth. Current implant options are homografts and xenografts, which are human tissue and 
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animal products, respectively. Limited supply and fixed size of the conduits are major 
shortcomings of homografts and to a lesser extent, xenografts. Tissue engineering (TE) seeks 
to address these limitations through synthesis of a biocompatible material that replicates the 
mechanical properties of the native tissue. Planned degradation of the biomaterial over time 
and replacement with host tissue may produce apparent enlargement of the RV-PA connection, 
although true ‘growth’ has yet to be realised. Tunability of the material properties and the 
possibility of 3D printing customised designs are additional advantages of tissue engineered 
conduits compared with homografts and xenografts. However, biocompatibility or non-
immunogenicity remains an important issue before clinical translation of tissue engineered 
conduits is possible [5]. 
Computational models provide insights into mechanisms that may accelerate structural valve 
and conduit deterioration and shorten the useful life of the implanted valved conduit. In 
conjunction with patient-specific optimisation of design, computational models allow iterative 
improvements in conduit shape and impact of various novel biomaterials. Wall shear stress 
(WSS) and its minimisation in conduit design is central to minimisation of structural 
deterioration and its impact on the right ventricle.  
Currently, the main determinant of the conduit diameter is body surface area (BSA), and 
nomograms linking ‘normal’ pulmonary arterial size to BSA guide surgeons in determination 
of ‘ideal’ size. As current conduits don’t grow, an attempt to ‘oversize’ with respect to the BSA 
at the time of operation is usually undertaken. Factors other than simple conduit diameter, 
including turbulence of flow and energy loss, as well as the position of the sternum and aorta 
should be considered in design of conduit shape. Consideration of these factors could be 
expected to increase the durability and reduce right ventricular work. Reduction of right 
ventricular pressures will also reduce the risk of aneurysm formation in the proximal conduit. 
These considerations are especially important for the RV-PA implant as the pathway from the 
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right ventricle to the pulmonary artery is inherently convoluted due to the different antero-
posterior planes that the surface of the right ventricle and pulmonary arteries are in, as well as 
the fixed position of the sternum and aorta that may cause geometric distortion or compression. 
Patient-specific modelling and simulation can therefore lead to a better design and performance 
as they provide insight into factors, such as mechanical energy loss, stress distribution, and 
flow turbulence, that are otherwise difficult to model.  
Computational methods decrease the need for in vitro and animal tests in the design process as 
they provide a preliminary assessment of the performance of the prostheses by changing design 
factors. Simulations are much less time consuming and costly than other testing methods and 
the parameters in simulations can be changed effortlessly.  
Moreover, integration of computational methods with current medical imaging techniques 
allows patient-specific design optimisation of the implants according to each individual’s 
anatomy. It provides invaluable clinical information that streamlines diagnosis and treatment. 
It should be noted that these data are more reliable when the models are not oversimplified or 
incomplete. This is inherently challenging in clinical circumstances, due to the lack of precisely 
measured cardiovascular data to feed into the models, the complexity of the geometries, and 
the multiscale nature of the system [6]. 
1.2 Objectives 
This study is part of a larger project with the ambition of 3D printing customised RV-PA 
conduits with growth capacity for use in surgery for the treatment of a subset of congenital 
heart diseases. The focus of this study was on developing a methodology for integration of 
clinical data with engineering techniques to construct patient-specific models that can be used 
for optimisation of the geometrical design of the conduit. Patient-specific models were 
constructed using the clinical data of six patients and Computational Fluid Dynamics (CFD) 
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analysis was employed for design modification. Structural analysis was also utilised to evaluate 
the performance and optimise the dimensions of a tissue engineered material developed by 
other team members. 
1.3 Thesis structure 
The remainder of this thesis is structured as follows:  
• Chapter 2 (Literature review): presents a review of relevant studies on computational 
methods for simulating blood flow through the arteries, the geometry construction 
process, biological data and boundary conditions to be used in simulations. 
• Chapter 3 (Methods): describes the methodology employed in this study for 
construction of patient-specific models to replicate blood flow through the RV-PA 
conduit and design customisation of the conduit. It also elaborates on the indices that 
have been used to evaluate the performance of the modified designs and compare them 
with current clinically used conduits. 
• Chapter 4 (Results and discussion): compares the performance of proposed patient-
specific designs of the conduit with current clinically used options using the methods 
developed in Chapter 3.  
• Chapter 5 (Computational modelling in material assessment): describes the application 
of computational modelling in expediting the process of material design by providing 
a rapid means of performance prediction and evaluation. It also provides a comparison 
of initial and modified geometries using structural analysis. 
• Chapter 6 presents the conclusions arising from this study and some ideas for future 
work.  
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2 Literature review 
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2.1 Overview 
This Chapter seeks to provide a comprehensive review of advancements in computational 
modelling of the cardiac arteries and implants with a focus on the applications for the design 
of the RV-PA conduit. In section 2.2, background physiological information is provided. 
Computational methods for simulation of blood flow in arteries are the subject of section 2.3. 
The geometry construction process is presented in section 2.4. In sections 2.5 and 2.6, 
biological data and boundary conditions used in simulations are described. Section 2.7 reviews 
the performance indices that characterise the performance of the conduit. In section 2.8, similar 
studies on integrating medical imaging and computational modelling for design modification 
of cardiac implants are reviewed. 
2.2 Physiology of the heart and its defects 
A normal heart consists of four chambers: two atria and two ventricles. During diastole, the 
heart chambers are relaxed, and blood fills the two atria. During systole, the heart muscle 
contracts and blood is pumped from the left and right ventricles to systemic and pulmonary 
circulation, respectively. The systemic circulation sends oxygenated blood to the body parts 
and the pulmonary circulation sends deoxygenated blood to the lungs to become oxygenated. 
The main focus of this study is the subgroup of CHDs that require implantation of a right 
ventricle to pulmonary artery (RV-PA) conduit as part of the surgical pathway. Examples 
include truncus arteriosus and pulmonary atresia with ventricular septal defect (VSD).  
Complete absence or valvar obstruction of the pulmonary artery is named pulmonary atresia 
(Figure 2.1A), and when a ventricular septal defect is present, interventricular mixing allows 
apparently normal left and right ventricular chamber development in utero. The survival of 
patients with this condition is dependent on the persistent patency of the ductus arteriosus 
between the aorta and the pulmonary arteries that carry the blood to the lungs [7]. In the absence 
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of this connection, there is profound cyanosis (low oxygen levels), often manifesting in the 
first hours of life.  
Truncus arteriosus arises as a failure of the normal processes of separation of the systemic and 
pulmonary outflows, with persistence of a single outflow structure (the truncus) from the heart, 
feeding both the systemic and pulmonary circulations (Figure 2.1B). It is almost always 
associated with a VSD.  
The definitive repair procedure for both PA-VSD and TA involves patch closure of the 
ventricular septal defect and creation of an extra-anatomic connection between the right 
ventricle and the pulmonary arteries, utilising a RV-PA conduit (Figure 2.1C, PA-VSD repair 
demonstrated). Patients benefit from a valved conduit, as the right ventricle copes better in the 
absence of pulmonary regurgitation.  
 
Figure 2.1 Common heart defects: (A) pulmonary atresia with VSD, (B) truncus arteriosus with VSD, 
(C) the combination of procedures required to repair the defects. 
The proximal part of the conduit is connected to the margins of a right ventriculotomy, an 
incision made by the surgeon to access the ventricular septal defect through which the right 
ventricle will expel the blood, into the conduit, as the RV then has no other outlet. To ease the 
pathway from RV to the conduit, and to allow the valve to sit distally and away from potential 
sternal compression, a ‘hood’ is often required to roof over the connection between the RV and 
the conduit. Bovine pericardium is often used to create such ‘hoods’ and the technical 
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performance of this connection is subject to substantial variation as a result of differing patient 
anatomy and surgical approach. It is an example of the modifications that are required, 
sometimes at both ends of the conduit, to accommodate the available conduit into the individual 
patient. Details of the creation of RV-PA connection in truncus arteriosus are illustrated in 
Figure 2.2, images are taken from [8].  
 
Figure 2.2 Creation of RV-PA conduit in truncus arteriosus: (A) starting pathology (on the left), 
repaired truncus – VSD closed and RV to PA connection made (on the right), (B) the VSD is closed 
through an incision in the RV and the homograft is used to create the distal part of the RV-PA pathway, 
(C) the pathway is completed with a patch to close over and augment the opening in the RV. 
Both definitive operations may be performed in the days to weeks following birth and this is 
the contemporary approach to repair of TA. Conventional approaches to PA-VSD usually 
involves creation of a temporary source of pulmonary blood flow, either by creation of a 
systemic to pulmonary arterial shunt or stenting of the ductus arteriosus (not shown). This 
Page | 10 
 
allows deferral of the larger ‘repair’ operation for 3-9 months and may promote growth of the 
native pulmonary arteries.  
2.3 Computational methods for simulation of blood flow in arteries 
Simulation of the blood flow through the implants under physiological conditions can provide 
valuable insights into underlying factors that can be utilised to enhance conduit design. 
Computerised simulations provide information about the haemodynamic attributes, stress 
distributions and other data that are derived attributes and not captured through evaluation of 
physical structures. They assist with predicting and optimising post-operative haemodynamic 
characteristics and therefore enhancing the procedure outcome. In this section, a brief overview 
of computational methods that can be utilised for the study of the cardiovascular system is 
provided.  
Computational techniques in modelling RV-PA conduits require these components (Figure 
2.3): (1) geometry acquisition/construction (Section 2.4), (2) biological data including blood 
model and material model of the artery walls (Section 2.5), and (3) defining realistic boundary 
conditions over the cardiac cycle (Section 2.6).  
In this work, CFD analysis is employed. CFD is a method for simulating fluid passing through 
or around an object, in this case the conduit. Generally, CFD models are based on solving the 
Navier-Stokes and other continuum equations; the inputs are usually flow rates, internal forces 
and stresses and the resulting outputs can be deformations of the vessel wall and fluid 
dynamics. For a very few special geometries and boundary conditions, these equations are 
simplified in a way that their solution can be obtained as a function of space and time using 
analytical methods. Otherwise, the solution generally needs to be obtained by numerical 
approximation, where the solving process starts from a rough estimation of the solution and an 
iterative algorithm is employed to modify the solution at each step. The algorithm stops when 
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two consecutive solutions show an insignificant change. Elaborate theory exists surrounding 
the stability and convergence of numerical approaches that is outside of the scope of this 
Section. There are several open-source and commercially-available CFD software packages 
that facilitate the completion of these calculations [9-11]. 
 
Figure 2.3 Simulation components. The patient-specific geometry in this figure is constructed from 
segmentation performed on a patient’s MRI data (top, left). Mechanical properties of the artery walls 
need to be added to the model (top, right). An example of patient-specific boundary conditions is shown 
on the bottom. Velocity obtained from patients’ echocardiogram (left) can be imposed as an inlet 
boundary condition (right). Selection of boundary conditions can vary in each case. 
Numerical flow calculations require splitting the flow domain into many small volumes. The 
governing equations are then approximated and solved to provide values for each of the 
volumes (usually called the mesh). Various discretisation methods can be employed. Space 
discretisation methods are based on dividing the solution space into a finite set of points. The 
‘Finite Differences’ approach uses a local Taylor expansion to approximate the differential 
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equations on the discretised points [12], and ‘Finite Volume’ method uses the integral form of 
the equation over discretised volumes [13].  
Another set of numerical approaches are Galerkin methods, which include Spectral Methods 
and Finite Element analysis. These methods are based on approximating the solution by 
assuming it is a function of a finite set of basic functions [14]. These approaches are 
theoretically stronger than spatial discretisation and guarantee more accuracy, although 
application to complex geometry is more difficult.  
Regardless of the method employed, the result will be a set of coupled, non-linear algebraic 
equations that are solved iteratively until convergence is obtained. For a reliable simulation 
practice, mesh-independence tests should be performed to ensure that the solution does not 
show significant changes with mesh refinement. 
Researchers have also endeavoured to develop computational methods that have capabilities 
beyond that of traditional Finite Elements Analysis approaches. An example of these 
advancements is IsoGeometric Analysis (IGA) [15]. IGA uses CAD tool “NURBS” (Non-
Uniform Rational B-Splines) to construct the exact geometry. The mesh is also created using 
NURBS elements. This eliminates the need for communication with CAD for further mesh 
refinements once it is constructed. Another advantage of IGA is the geometrical accuracy of 
the model despite the coarseness of discretisation. 
In a case where a solid structure interacts with the flow, and deforms and moves according to 
flow, such as biological valves, a Fluid-Structure Interaction (FSI) analysis is required. This 
analysis is more complicated as it needs to account for transfer of information between solid 
and fluid subdomains (meshes). FSI algorithms can be mainly categorised as conforming mesh 
and non-conforming mesh approaches.  
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The general concept behind conforming mesh methods is dividing the region of interest into 
liquid and solid part and solving each part separately according to Navier-Stokes and stress-
deformation equations, respectively. Here, re-meshing is required as a result of solid 
deformations and transformations to liquid or vice versa. The immersed boundary method [16] 
is the most popular of the conforming mesh approaches. Non-conforming mesh methods, 
however, solve the solid and fluid equations independently by adding the interactions (forces 
and deformations) between the fluid and the solid as terms in the momentum equation. 
A major limitation of both approaches is their inability to solve problems where transitions 
between solid and fluid part occurs, such as blood clotting and calcification. Introduction of a 
mesh-free approach [17] strives to overcome this limitation by treating both solid and fluid as 
computational particles. The distinction between the domains, in this method, is applied by 
acknowledging the different forces that act on particles: pressure and viscous forces for liquid 
and elastic forces for the structure. 
2.4 Geometry construction 
The geometry construction can be done in four steps: 1) medical imaging, 2) image 
enhancement, 3) segmentation, and 4) meshing. Each of these steps are elaborated upon 
hereunder. 
2.4.1 Medical imaging modalities 
Angiography and ultrasound are two imaging methods that are used mostly to acquire 2D 
images, however reconstructing a 3D volume from 2D slices is also possible. Ultrasound 
exploits the reflections of high-frequency sound waves transmitted into the body to construct 
images. Ultrasound is the cheapest and the least invasive method of medical imaging, however, 
its spatial resolution is the poorest [6]. 
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In angiography, a radio-opaque dye is injected into a small tube or catheter that is put in the 
body, and after the injection, pictures are taken using an X-ray machine by projecting X-ray 
beams on the body. Rotational angiography (RA) allows construction of 3D volumes by 
rotating a C-shaped arm around the subject to acquire a few hundred 2D slices. A reconstruction 
algorithm is then used to construct a 3D volume [18].  
Another widely used technique for image acquisition based on X-ray angiography is computed 
tomography or CT-scan. A CT scan processes many X-ray measurements taken from multiple 
rotating X-ray sources and detectors using advanced reconstruction algorithms to produce 
many cross-sectional images of specific areas of the scanned object. Current CT devices 
provide sub-millimetre spatial resolution, which in combination with CFD can enable 
calculation of flow and pressure fields [19]. Recently, a dynamic CT has been developed that 
allows one to evaluate flow dynamics by constructing multiple 3D volumes through a heartbeat 
[20]. The drawbacks of CT include high radiation levels, which can have negative effects on 
patients. 
Doppler echocardiography is an imaging technique that is used for acquisition of images of the 
cardiovascular system. Doppler echocardiography creates images of the heart by utilising high 
frequency ultrasonic sound waves, while the direction and the speed of blood flow is acquired 
using the Doppler effect. This is a non-invasive tool that provides insight into haemodynamic 
evaluation of the heart by allowing measurement of pressure gradients, intracardiac pressures, 
valve areas, regurgitant and shunt volume [21]. The major limitation of 2D echocardiography 
is that the measurements are angle-dependent as they are calculated under a planar flow 
assumption, and the ultrasound beam should be as parallel to the blood flow direction as 
possible, which increases the potential for user-error. Echocardiography is used clinically as a 
bedside tool for assessment of structure and function and is the initial modality employed to 
evaluate conduits serially over years of patient follow up. When significant stenosis is 
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identified, clinicians usually arrange a form of cross-sectional imaging (CT or MRI) to confirm 
expected findings and assist in surgical planning for replacement of the conduit.  
Finally, cardiovascular magnetic resonance (CMR) is mentioned. CMR creates images from 
atomic nuclei with uneven spin in the presence of a magnetic field using radio waves. The 
difference between the ratio of reflected energy from various body structures is the principle 
MR is based on. The flexibility in tuning the RF stimuli allows elucidation of soft tissues. MR 
is less invasive than angiography as it does not require injecting foreign agents into the body. 
However, a contrast agent can be injected in the blood to enhance the quality of the images. 
MR is also safer than X-ray analysis and allows acquisition of highly-resolved spatial and 
temporal data simultaneously, which in turn enables direct 3D visualization of blood velocities, 
flow rate, and even WSS. Flow rate data are available in CMR since the cross-sectional area 
of the vessels is captured in addition to velocities. CMR does not require ionising radiation. 
A variety of CMR types exist that use various physical rules to produce case-specific data. 
Examples are cine CMR, flow CMR, tagged CMR, DENSE CMR, etc., descriptions of which 
and their applications can be found in [22]. New 4D flow sequences, allow for examination of 
more complex fluid dynamic characteristics, such as helical flow patterns, however they 
require long acquisition time and complex post-processing [19]. 4D phase contrast (PC)_MRI 
can be used to compare the imaging data and CFD-derived velocity fields. Also, the velocity 
mapping resulting from PC_MRI can be applied to obtain volumetric flow measurements, 
detect stenotic flow, derive velocity and flow patterns, as well as vessel WSS and pulse wave 
velocity [23]. 
2.4.2 Image enhancement 
Medical imaging, as with any other imaging, is prone to noise that affects the quality of the 
data. The main objective of image enhancement is to boost the quality of the images by 
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removing the noise and providing better data for future image processing. Image enhancement 
techniques can mainly be categorised as spatial domain and frequency domain methods.  
Spatial domain methods, such as log transformation, piecewise linear transformation and power 
law transformation, operate directly on the pixels and enhance the contrast. Frequency domain 
methods, however, work with the Fourier transform of the image. Both approaches have low 
computational complexity. However, the frequency domain method can only focus on specific 
parts of the image and cannot improve the entire image. The major drawback of the spatial 
domain method is the lack of robustness [24]. The choice of enhancement technique is 
dependent on the type of noise and interference, as well as the application. 
The noise in the medical images may be due to thermal effects in the signal processing 
electronics or other undesired sources [6]. Regardless of the source, most image processing 
techniques assume the noise to be additive with a zero-mean, and to have a constant variance 
with a Gaussian or Poisson distribution. These assumptions generally assist with simplifying 
the image filtering. However, to achieve a better quality of processed images, a more informed 
model of the noise is required. For instance, a study [25] suggests modelling noise variance by 
a nonlinear function of the image intensity that is dependent on parameters related to the image 
acquisition method. 
Contrast enhancement is an important element in improving medical images, since it is the 
main factor that makes objects in the body separate from their surrounding structures. 
Algorithms such as INT Operator, Type-1 Fuzzy and Type-2 Fuzzy can be utilised to perform 
contrast enhancement. INT has been shown to be the most effective in simple medical images 
[26]. Histogram modification and tone mapping are two other contrast enhancement techniques 
that have been used for image processing for medical applications [24]. 
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By the end of image enhancement process, a modified image intensity matrix is obtained that 
contains the image data that can be used for the next steps that lead to the construction of the 
geometry. Obviously, the number of points in the matrix of the enhanced image is greater than 
the number of points in the matrix of the initial image.  
2.4.3 Image segmentation 
CFD simulation can be done on a high-resolution geometrical model of the region of interest. 
This means that the data acquired from medical imaging should be processed and segmented 
to be suitable for simulation purposes. Therefore, image segmentation is a key element in the 
image processing steps. It is used to construct the shape of the region of interest by defining its 
boundary. The precise definition of the boundary is a challenging task and when working with 
medical images requires considerable experience and knowledge of the anatomy from the user. 
There are various automatic and semi-automatic approaches for segmentation that are based on 
different fundamental principles [22].  
Thresholding is a method based on the intensity histogram of the image. It assumes that pixels 
belonging to the same intensity interval correspond to the same tissue, and on this assumption 
divides the image into several modes. This method is only effective when there is a significant 
gap between the intensity of the desired region of interest and its background, for instance if 
the target is bone. However, in most cases the intensity of different tissue types is very close, 
hence, thresholding needs to be combined with other approaches to improve the results.  
Another technique for segmentation is region-growing that is often integrated with 
thresholding [27, 28]. This technique starts at a point in the image matrix and tries to find 
similar pixels in the neighbourhood and adds them to the region. The region stops growing 
when none of the points in the neighbourhood qualify for becoming a member of the region. 
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One of the deficiencies of this method is ‘overgrowing’ when there is similarity between target 
tissue and its surrounding tissue. 
Pixel-voxel classification is another version of segmentation that categorises pixels in 2D or 
voxels in 3D based on their features (e.g., contrast, area, and circularity). To do this, a manually 
labelled training data set is needed, however, some methods such as K-means clustering, or 
expectation-maximization do not require training data. Another set of methods that are based 
on active contours search for target walls instead of categorizing the regions. A comprehensive 
review of segmentation methods can be found in [22]. 
Most of the abovementioned methods require user input in the form of manual segmentation 
on training sets or placing landmarks or specifying some boundary contours. However, 
automatic 3D segmentation tools, such as MITK, seg3D, and ITK-Snap, have been developed 
that can be used to construct geometrical models with little or no user input. The custom 
package CRIMSON [9] offers semi-automatic segmentation tools whereby manually 
constructed centrelines and two-dimensional (2D) segmentations of the vessel lumen are used 
to create a CAD model of the vessels of interest via lofting operations. The commercial product 
Materialise Mimics [29] and the open source Vascular Modelling toolkit [30] are other notable 
examples of semi-automatic segmentation software.  
In addition, automatic 2D segmentation can be applied at several discrete locations of the 
interested area, which then can be lofted together using B-splines (NURBS) to produce a 
smooth model of the vessels that can be used for meshing. The sharp edges between branching 
vessels should be removed through blending techniques [31]. Another method is triangulation 
of the surface of the model using direct 3D segmentation, which is suitable for 3D-printing as 
it is lightweight. 
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These tools only work well in the case of high-resolution image data or they might create 
artefacts that then need to be repaired manually, which requires a high technical capability of 
the user. The intrinsic complexity of the heart, high interpatient-variability, and unavoidable 
imaging imperfections are some of the challenges that must be overcome before automatic 
segmentation can produce reliable data. 
2.4.4 Meshing 
Segmentation allows us to identify the boundaries of the region of interest. The next step is 
meshing of the volume that will make CFD modelling and finite element analysis possible. 
Tetrahedrons are one of the best options for meshing of medical geometries due to their 
flexibility in filling volumes with complex shape. Delaunay triangulation and advanced front 
(AF) are two main approaches for construction of unstructured tetrahedral mesh [32].  
Triangulation makes a surface mesh. In AF, first a boundary surface mesh is generated. Then 
mesh elements are created by inserting one new point or merging different existing points. The 
major drawback of this approach is the complexity of the analysis of the target region and 
surroundings of mesh elements. Delaunay can directly generate volumetric mesh using special 
algorithms that are discussed in detail in [33].  
The mesh quality is important in both accuracy and convergence of algorithms for the solution 
of the PDE of interest. There are several quality determinants that can be utilised to assess the 
mesh quality, such as node point distribution, smoothness, and skewness. Skewness is the most 
significant as it quantifies mesh distortion, which is caused by the presence of very small angles 
that will affect the convergence and degrade the solution accuracy.  
The mesh refinement process usually continues until no significant changes in the output results 
is noticed. WSS is one of the important target outputs that is studied in simulations of the blood 
flow in the arteries. To capture WSS accurately even at low Reynold numbers [34], 
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employment of a boundary layer mesh is necessary [35]. Three or four layers of boundary mesh 
are normally adequate. 
2.5 Biological data 
The values of physical parameters appearing in the differential equations that describe the flow 
in a conduit should be determined. This can be categorised into fluid and solid properties. 
2.5.1 Fluid domain 
If a fluid is considered Newtonian, the flow simulation can be characterised by its density and 
dynamic viscosity (blood). Blood density does not noticeably deviate from an average value of 
1.06 g cm-3. Typical Reynolds numbers in large arteries are in the laminar range [36]. Viscosity, 
however, can vary between 0.03-0.04 g cm-1 s-1 [6]. But, no patient-specific measurements are 
usually made, and a value in this range is normally chosen. 
Experimental studies, however, show that blood is a non-Newtonian fluid and it can exhibit 
shear thinning, thixotropic, viscoelasticity and yield stress characteristics depending on flow 
shear rate history [37]. However, at shear rates greater than 50 s-1 the blood viscosity remains 
constant, hence often justifying the assumption of Newtonian flow in the model [38]. The shear 
rate in turn depends on the size of the blood vessels and flow behaviour. Generally, shear rates 
in large arteries are high. However, conditions such as stenosis that lead to recirculating zones 
and stagnant regions cause a decrease in shear rate, which gives rise to the need for non-
Newtonian modelling [39]. In addition, it is shown that the non-Newtonian properties of blood 
in a pulsatile flow are remarkable around the time when the velocity and velocity gradients 
approach zero [40]. 
Generalised Newtonian models are amongst the most popular models that are very efficient for 
modelling healthy arteries. Examples are Carreau, Carreau-Yasuda, Cross, and Powell-Eyring. 
For modelling capillaries and porous structures with very low shear rates, yield stress models 
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such as Casson, Bingham and Quemada are more suitable. Viscoelastic models, such as the 
Maxwell model, are the only options that are capable of including shear-thinning and stress-
relaxation features of fluid. A comprehensive review of non-Newtonian blood models can be 
found in [36]. 
Studies have endeavoured to investigate the effects of using various blood models on the results 
of simulations of different parts of cardiovascular systems. While many of these studies 
conclude that non-Newtonian blood models have a significant effect on haemodynamic 
parameters, many find the discrepancies between the results of Newtonian and non-Newtonian 
simulations insignificant [37]. This reconfirms the statement that the influence of blood model 
on results is case-dependent. For instance, Johnston et al. [41] and Weddell et al. [42] studied 
femoral artery tree and coronary artery, respectively, and showed significant change in WSS 
distribution. However, studies on bypass arteries grafts [43], aorto-coronary bypasses [44], and 
abdominal aortic aneurysm [45] have shown modest changes in haemodynamic parameters. 
Valencia et al. [46] suggests that a non-Newtonian model of blood flow is more relevant in 
modelling of a carotid artery with aneurysm. Many other studies on arteries with aneurysm [47, 
48] have reached the same conclusion, therefore Ho et al. [49] suggests employing non-
Newtonian model in pathological conditions. 
2.5.2 Conduit material 
Ideally, the implant material is durable, has the capacity to grow with the child and does not 
provoke an immune response in the body. A large gap exists between current options and the 
ideal implant, each option has their own strengths and weaknesses. Today, human pulmonary 
artery tissue or ‘homograft’ is commonly used for RV-PA connection. However, limited 
supply, especially in smaller sizes appropriate for infant procedures, has led to utilisation of 
substitutes from animal products that are known as xenografts [50]. An example is bovine 
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jugular vein (BJV) graft [51], which is popular due to its availability in a range of sizes. 
However, compared with homografts, xenografts may be associated with development of distal 
stenosis and a higher rate of infective endocarditis [52-54]. Expanded polytetrafluoroethylene 
(ePTFE) and polyethylene terephthalate (Dacron) are other materials that have been used for 
right ventricle outflow tract (RVOT) reconstruction however PTFE is not usually a valved 
connection and Dacron is no longer in widespread use [55, 56]. 
The mechanical properties of the graft material have a significant impact on its performance. 
Ideally the graft would replicate the behaviour of the native artery. The impedance of the vessel, 
which represents its resistance to pulsatile flow is a key mechanical feature of the vessel. The 
impedance depends on resistance to constant flow and the fluid inertance, which are constant, 
and the compliance of the conduit that is modifiable [57]. Hence, a compliance study can 
provide insight into the effectivity of the graft. Compliance expresses a dimensional change 
with respect to luminal pressure change and is defined by the following equation: 
Equation 2.1: Compliance = 𝑑𝑑
2𝐸𝐸𝐸𝐸
 
in which d is the vessel diameter, t is the wall thickness, and E is the Young’s modulus of the 
wall tissue. Compliance mismatch between the host and the graft might bring about damage to 
endothelial cells, increase oscillatory forces that weaken the graft, and lead to areas of relative 
stasis [58]. Hence, the goal is to minimise the mismatch between compliances of the native 
artery and the graft noting that current materials used clinically are almost always seen to be 
rigid at the time of explantation for structural deterioration.  
The mechanical properties of the conduit material need to be included in the model. Proper 
definition of these properties is not an easy task, since the data measured from limited samples 
can hardly be generalised to all cases due to the broad range of variations. Moreover, 
decellularization and maintenance methods can affect the mechanical properties [59]. Even if 
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measurements are done on the exact same material, it is unlikely that those properties remain 
the same when put in the body. 
There are methods for patient-specific measurement of mechanical properties. An example is 
elastography where elastic modulus is obtained by solving an inverse problem from the 
available displacement field [60]. Another method is characterisation of the arterial wall 
structure by estimating pulse wave velocity using MR imaging [61].  
The parameters required to define mechanical properties for the model depend on the 
constitutive law that is used to describe the behaviour of the material. The most common 
parameters used are density, elasticity and incompressibility. If a linear elastic model is used, 
the latter two are quantified by the Young’s modulus and Poisson ratio, respectively. An 
acceptable Poisson ratio for all options is 0.49 that is quasi-incompressible instead of the value 
of 0.5 that gives incompressibility and can lead to computational instability [6].  
Linear elastic models, however, are only suitable if the displacement gradient is small and the 
stress-strain relationship is linear. This is not always the case, particularly in modelling of the 
valve motion, where simplistic material models can result in misleading results. Hyperelastic 
models are more sophisticated alternatives to linear models that have been commonly used for 
characterising many soft biological tissues [62, 63]. The most popular hyperelastic material 
model is the exponential model introduced by Fung [64]. Moreover, including anisotropic 
features of the material in the model can affect the stress distribution [65], which is a significant 
determinant in valve design. A review of material models for valve leaflets can be found 
elsewhere [66]. 
2.6 Boundary conditions 
For a properly defined simulation boundary conditions should be prescribed on all inlets, 
outlets and walls. Boundary conditions are derived either from physical principles or medical 
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measurements. An example of application of physical rules is assuming fluid particles adhere 
to the conduit wall perfectly, therefore the velocity of the flow at boundary layer is zero. 
Therefore, the no-slip condition can be prescribed on the conduit wall. At the inlet and outlet 
of the conduit velocity or pressure data acquired from clinical measurements can be applied.  
Ultrasound is a non-invasive method of acquiring boundary condition data. By exploiting the 
Doppler effect, the velocity of the blood in the direction of the ultrasound beam can be obtained. 
The velocity data can also be converted into flow rate data across a specific cross-section if 
required. Another non-invasive method of measuring volumetric flow rate is using thermal 
imaging [67]. This method exploits the convective heat transfer relationship between the flow 
rate and the temperature of the flowing liquid.  
More elaborate boundary conditions can be employed when velocity data at several points (as 
opposed to single point in previous methods) on the same cross-section are available. PC_MRI 
is an example of where velocities at several points on the same cross-section can be decoded 
from images that are taken at several instants during the heartbeat.  
The spatial resolution of modern PC_MRI is often lower than the appropriate mesh size. Hence, 
to obtain a usable boundary condition, interpolation may be needed. An advantage of 4D flow 
methods such as PC_MRI and 4D_CT is that they can provide information about parameters 
such as displacement of the conduit wall, where physical principles are already used to 
prescribe boundary conditions, or internal velocities. In this case, the extra information can be 
utilised for validation of the numerical results. 
Pressure is another clinically acquired parameter that can be used as a boundary condition. This 
can be obtained non-invasively, using sphygmomanometer, echocardiography, applanation 
tonometry, or invasively, using catheterization.  
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Applanation tonometry (AT) extracts the shape of the central pulse pressure waveform from 
the radial artery and therefore overcomes the limitations of peripheral pressure measurement 
[68]. In the AT process, mild pressure is applied on the radial artery by placing a strain gauge 
pressure sensor (tonometer) over the artery. The recordings of the sensor are then transformed 
using validated transfer functions to calculate central pressure indices [69]. In cases where 
continuous monitoring of the pressure or measurement of lower pressures is required, a catheter 
with a transducer can be placed in the region of interest that can measure the average pressure 
over a cross-section. 
A limitation of simultaneously prescribing time-varying velocity or pressure profile at the inlet 
and outlet, which is exploited in many studies, is that acquiring accurate data simultaneously 
at multiple outlet branches and synchronizing them is impractical. Also, the distribution of flow 
and pressure is part of the desired solution, and prescribing values at the outlet might prevent 
a realistic outcome of the simulation. Instead, applying the relationship between flow and 
pressure as outflow boundary condition can increase accuracy of the simulations. For this 
matter and in cases where sufficient clinical data are not available, reduced order or lumped 
parameter models are used to prescribe the boundary conditions on the region of interest.  
One of the most popular lumped parameter models in cardiovascular studies is the Windkessel 
model [68]. This model derives an analogy between arteries and an RCR electric circuit with a 
series proximal resistance with a parallel arrangement of distal resistance and a capacitance. 
The pressure and flow in the artery are analogous to the voltage and current in an electrical 
circuit, respectively. These models have the capability to capture transient responses of the 
system. For example, a study [70] uses a RCR model and shows that this model can account 
for aperiodicity of the inlet waveform, which can arise from many factors such as respiration, 
heart rate variability, and exercise. Another study [71] compares the aortic flow resulting from 
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five methods of prescribing outflow boundary conditions and shows good agreement between 
the haemodynamic achieved by the Windkessel model and in vivo data. 
Finally, another remaining restriction in surgical planning is using pre-operative flow 
waveforms and other clinical measurements as boundary conditions for the proposed surgical 
option to simulate blood flow through the new connection and calculate relevant parameters. 
This method is clearly limited from a physiological view. 
2.7 Indices characterising the performance of cardiovascular implants 
In this section, the indices that characterise the performance of the cardiovascular implants is 
described. An important haemodynamic element in design optimisation of implants is WSS. In 
human coronary arteries, WSS is correlated with clotting, haemolysis, blood damage, plaque 
destabilization, thrombosis, and rupture [72]. Blood clotting plays an important role in many 
cardiovascular complications and causes of death as relates to small vessels, including coronary 
vessels. Platelet activation is an indicator of blood clotting and has been shown to be a function 
of high WSS and exposure times [73]. Although less of a problem in larger vessels because of 
the larger luminal size, such sequelae of elevated wall stress are also relevant to large vessels 
including the RV-PA connection. A study on aortic coarctation [74] draws correlation between 
long-term morbidity and time-averaged WSS and oscillatory shear index. Determination of the 
stress distribution also identifies the points at which the implant is more susceptible to 
structural deterioration and hence reduced durability. 
Evaluation of conduit design related to the Fontan circulation, where IVC-PA connection is 
required, also illustrates concepts that are relevant to the modelling in the RV-PA context. The 
performance of an IVC to PA connection can also be characterised by other factors, such as 
power loss (PL) and hepatic flow distribution (HFD). Unbalanced HFD leads to differential 
growth of pulmonary arteries, which in turn affects the resistance to blood flow and alters 
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distribution of blood to each lung [75]. PL is indicative of efficiency of the implant. It is 
speculated that high PL would correlate with low exercise capacity and exert high pressure on 
the ventricle as it needs to compensate for the lost energy.  
Therefore, if the design of the implant can be improved to achieve balanced HFD, minimise 
PL, and optimise stress distribution to increase the durability, it may be beneficial for the 
patient. Furthermore, utilising computational models in the design and optimisation process, 
decreases the number of in-vitro experiments required to evaluate the design. 
It should be noted that PL is dependent on multiple factors. A study [76] derived an indexed 
energy dissipation model that illuminates effects of governing variables such as cardiac output, 
flow split, Reynolds number, and minimum PA size on PL. Therefore, one can normalise PL 
to achieve an expression that is solely a function of geometrical factors, such as curvatures, 
angles and orientation of the vessels. 
Returning to the RV-PA context, additional factors can be studied to evaluate both the 
performance of the conduit but also the circulatory circumstances into which a new conduit is 
placed. Volume-based indices such as RV ejection fraction, end-diastolic and end-systolic 
volumes, RV mass, and peak ejection and filling rate, and pressure-based indices can be 
investigated to predict the RV-PA dysfunction. However, for comprehensive assessment of 
RV-PA function, energy-based analyses that incorporate both pressure and volume are most 
reliable. Examples include the ventricular pressure-volume relationship, ventricular stroke 
work and efficiency. 
Studies addressing the aortic valve and root complex also provide information relevant to the 
RV-PA context. Simulation of blood flow using CFD has given researchers more freedom to 
introduce case-specific energy-based indices, such as circulation energy dissipation, aortic 
valve energy dissipation and total TCPC energy dissipation index. In addition, emergence of 
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4D phased contrast MRI allows for complex blood flow visualization and calculating 
haemodynamic metrics, such as WSS, flow distribution, and more complex energy indices, 
such as turbulence kinetic energy [77, 78]. 
CFD and 4D-MRI can supplement each other to provide invaluable information, as 4D MRI 
can be used to validate CFD results and CFD can help overcome inaccuracies of 4D MRI that 
stem from low resolution and noise [79]. Computational modelling and 4D phase contrast MRI 
based methods have the advantage of being non-invasive and therefore more clinically 
valuable. 
2.8 Similar studies 
Although the number of studies that have used CFD to investigate RVOT flow dynamics are 
limited, many lessons can be learned from studies that have employed CFD to evaluate and 
optimise the geometrical design of systemic-to-pulmonary shunts, and Fontan geometries. This 
is because the performance metrics, such as energy efficiency and stress distribution, and the 
mechanisms that affect the durability of the implant, including the host response including 
platelet activation and potential for thrombosis, are similar in these cases. In this section, it is 
intended to give an overview of similar studies that have utilised patient-specific models and 
CFD analysis for cardiac surgical planning and implant design. 
Only a few studies have used finite volume methods to predict the flow dynamics in the RV-
PA conduit, specifically. Results of such simulations have shown good agreement with the 
observed clinical data, which proves the practicality of these methods in surgical planning [80]. 
A recent study [81] argues that pre-operative haemodynamic assessment of various surgical 
options can enhance the decision-making process provided that pre-operative boundary 
conditions are similar enough to post-operative states. It also highlights the contributions that 
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automation can make in streamlining surgical planning process. The time required for 
execution of each component of surgical planning is also estimated in that study.  
In first stage surgery for single ventricle conditions (a related condition but different to our 
focus on the RV-PA connection in pulmonary atresia and truncus arteriosus), small calibre non-
valved RV-PA PTFE grafts are used to create a source of pulmonary blood flow. Whilst the 
clinical context is very different there are learning points identified that are relevant to the 
surgical planning process. The radius of the RV-PA shunt has been shown to have a significant 
effect on pulmonary blood flow [80]. According to five geometries investigated in [82], the 
diameter of the graft is a stronger determinant of the fractional volume of the flow that is under 
pathologically high WSS, than the shape of the graft [82]. 
Many studies have investigated the influence of power loss and hepatic flow distribution on an 
implants’ performance and used these two factors to achieve better designs. Soerensen et al. 
introduced a haemodynamically-optimised total cavopulmonary connection with bifurcated 
caval connections using equi-sized connections to both PAs (Y-shaped graft or Y-graft) [83]. 
It was shown using CFD with simplified geometric models that the new design with curved 
junctions leads to more streamlined flow paths and lower fluid mechanical power losses 
compared with a 1D idealised model [84]. Yang et al. focused on hepatic flow distribution 
(HFD) in shape optimisation of the Y-grafts [85]. The impact of the pulmonary flow split, 
IVC/SVC (superior vena cava) flow ratio, and SVC flaring were examined for multiple designs. 
A flared SVC design was preferred over unequal-sized branches due to energy loss in the latter 
case. The optimised designs improved HFD by 79% and 94% in two patient-specific models 
studied. In a later study [86], they validated the abovementioned predictions by comparing 
simulation-derived HFD with in vivo lung perfusion data of the patients undergoing the 
procedure. However, the clinical implications, feasibility of implantation, risk of thrombosis 
and growth were not investigated.  
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Another patient-specific study [87], compares hepatic venous flow distribution of two surgical 
options pre-operatively using CFD, to suggest the better option. Fourteen surgical options in 
terms of HFD and PL are compared, and the work suggests that aiming for the mid pulmonary 
artery is robust strategy in achieving a balanced HFD, however, power loss did not change 
significantly between various options [75]. Another study [88] proposed a Y-graft with more 
clinical considerations allowing it to be used in procedures without cavopulmonary bypass, be 
custom manufactured, and specifically modified for individual patients. This approach 
improved the accuracy of haemodynamic evaluation of the graft by incorporating greater level 
of pulmonary branching, and the effects of respiration and cardiac contraction, as well as 
including resistance, impedance and lumped model boundary conditions. The study took 
advantage of the computational tools to compare pressures, energy efficiencies, flow 
distributions and wall shear stress (WSS) of the Y-graft, T-junction, and offset model. It 
demonstrated lower Fontan pressures, increased efficiency, and improved inferior vena cava 
(IVC) flow distribution in the proposed Y-graft design. The use of a rigid wall in the 
simulations and lack of patient-specific data for validation are some limitations of this study. 
In another study [89], the authors attributed the occurrence of thrombosis in one patient to low 
WSS and flow stasis and highlighted the effects of patient-specific factors on the performance 
of Y-grafts. However, thrombosis is a multifactorial problem. Also, effects of a deformable 
wall and suture lines involved in the grafting process were not investigated in the WSS 
calculations. A study of the carotid artery [90] compares the results of rigid-wall model with 
FSI simulation and shows larger backflow zone for the rigid-wall flow, hence highlighting the 
importance of accounting for deformability of the wall. 
In a recent study, a new approach was developed that integrated image data acquisition, 
simulation-based design, and validation of simulation results through in vitro testing. This was 
used to optimise patient-specific graft designs before manufacturing based on a balanced HFD 
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and minimal energy loss [91]. Utilization of electro-spun tissue-engineered vascular grafts in 
this study increased the degrees of freedom for graft design. The WSS profile and its effect on 
thrombosis, along with long-term durability of the graft are yet to be investigated. 
Capelli et al. [92] endeavoured to take a step towards clinical translation of FE simulations and 
CFD analyses by constructing patient-specific models of various CHD cases from 12 patients 
and validated the results of simulations against real immediate post-procedural results. Patients 
underwent procedures only when there was an agreement between the clinical decision and 
optimised surgical plan acquired from the simulations. This is one of the few studies that takes 
stents into account while constructing the model. Table 2.1 demonstrates model specifications 
and the parameters that were investigated in some of the above studies for surgical planning 
and design modification. 
With reference to design of the valve elements, the thrombogenic response to foreign bodies 
also represents a major clinical challenge that is currently chiefly managed by anticoagulants 
[93]. Surface factors, hemostatic factors, and haemodynamic factors are the main contributors 
to thrombosis. Many studies on prosthetic heart valves have employed CFD to evaluate and 
optimise their design, yielding the optimal haemodynamic and lowest achievable risk of 
design-related thrombosis [94]. However, prediction of thrombotic risks demand incorporation 
of a fluid structure interaction to account for wall deformations and to evaluate WSS accurately. 
The “Device Thrombogenicity Emulator (DTE)” has been proposed as a method that integrates 
numerical and experimental approaches to evaluate the design of prosthetic valves to achieve 
a better thrombo-resistance performance [95]. In the experimental phase, platelets are exposed 
to rapidly changing dynamic shear stress loading waveforms extracted from detailed numerical 
simulations. The extreme flow conditions are imposed and the resultant platelet activity, which 
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is indicative of blood clotting and thrombosis, is then measured. Similar approaches can be 
adopted to achieve lower risks of thrombosis in conduit geometries.  
The abovementioned strategies that have been previously used for the design of Fontan and 
TCPC geometries apply to RV-PA conduit too. However, despite its importance, fewer studies 
have focused on this specific geometry. In fact, RV-PA conduit might need more investigation 
due to its geometrical complexity and higher flow pressures as compared with Fontan and 
TCPC geometries. Patient-specific design of RV-PA conduits is especially important to avoid 
sternal and aortal compression. However, this has been mostly neglected in previous studies. 
This study endeavours to address this gap. The clinical translation of studies on implant design 
would be possible by integration of clinical data with tissue engineering and computational 
modelling techniques. This study also aims to take a step towards clinical translation by 
utilising computational modelling for evaluating the performance of a proposed synthetic 
material for the conduit, hence, expediting the material design process. 
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Table 2.1 Details of the modeling studies performed to date 
Region of study Geometry acquisition Simulation output Boundary conditions FSI* Reference 
Azygos vein, Fontan 
conduit, right and left 
pulmonary arteries, left 
and right innominate vein 
CT imaging and 
CRIMSON software 
HFD** Flow and pressure data from PC-MRI 
and cardiac catheterization, respectively. 
Three element Windkessel model 
no [87] 
Glenn model including 
pulmonary arterial 
branches and carotid 
bifurcation 
Magnetic resonance 
angiography and 
cineangiography 
Pressure 
velocity streamline 
WSS*** 
Inlet: echo-Doppler ultrasound 
normalised by flow from catheterization 
Outlet (various branches): RCR model 
yes [70] 
Fontan anatomy MRI or CT and 
Geomagic Studio 9.0 
HFD  
power loss 
Inlet: time-averaged flow curves 
Outlet: flow ratio from PC_MRI 
No [75] 
Modified Blalock-Taussig 
shunt 
Handmade according to 
CT 
WSS 
pressure drop 
Inlet: velocity wave form 
Outlet: ratio of mass flow 
No [82] 
RVOT, pulmonary trunk 
and the proximal branch 
of the pulmonary arteries 
along with the aortic root 
and coronary arteries 
CT or MR and 
Mimics, 
Simpleware ScanIp, 
VMTKLab, ITK-SNAP 
and OsiriX 
Pressure gradients 
maximum velocity 
 
 
Flow data from MR 2D phase contrast 
images and echocardiography. 
 
No [92] 
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Carotid artery CT  
Mimics 
Solidworks 
WSS 
pressure 
velocity 
Inlet: typical parabolic velocity 
Outlet:  zero static pressure 
Wall: no-slip 
Yes [90] 
Aorta Mimics 
ANSYS ICEM 
Pressure 
flow and velocity 
distribution 
WSS 
Inlet: pressure waveform and 3D 
velocity profiles from PC-MRI 
Outlet: Windkessel, fixed flow division, 
pressure waveform, zero pressure 
No [71] 
Aorta MRA or CT 
Simvascular 
MeshSim 
Cyclic strain 
WSS 
Oscillatory shear 
index 
Inlet: volumetric blood flow from 
PC_MRI 
Outlet: Windkessel 
Yes [74] 
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3 Methods 
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3.1 Introduction 
Six patients, three with PA/VSD (patients A, B, C) and three with TA (patients D, E, F) were 
selected. These patients had undergone surgery that included implanting a RV-PA conduit. The 
aim of this Section is to describe a method for customising the geometrical design of the 
implant to be used for replacement of the current conduit. Patient E had already undergone 
replacement of the initial RV-PA connection. The age of the patients at the time of the 
acquisition of MRI varies between 3-10 years. The details of their clinical situation and history 
are abbreviated in Table 3.1.  
Table 3.1 Patients’ age, condition and clinical history 
Patient Age at 
imaging date 
(years) 
Diagnosis Clinical history 
A 9 PA/VSD Age of 5 days: Central shunt 
Age of 1 year: Redo central shunt 
Age of 2 years: VSD closure, RV-PA conduit 
(Contegra* 22 mm) 
B 10 PA/VSD Age of 2 days: Left BT shunt 
Age of 1 year: VSD closure, RV-PA conduit (aortic 
homograft 19 mm) 
C 9 PA/VSD Age of 10 days: Primary repair and RVOT patch (at 
another institution) 
Age of 1 year: RV-PA conduit (homograft 12 mm), 
and LPA plasty (at another institution) 
D 8 TA Age of 12 days: Repair of TA, RV-PA conduit 
(pulmonary homograft 10 mm) 
E 6 TA/ aortic 
interruption 
(type B) 
Age of 6 days: Repair of TA and interrupted aorta 
(Goretex** tube graft) 
Age of 2 years: Replacement of conduit (aortic 
homograft 17 mm) 
F 3 TA Age of 15 days: Repair of TA, (Non-valved Goretex 
tube graft 10 mm) 
* Bovine jugular vein 
** Expanded polytetrafluoroethylene (ePTFE) 
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3.2 MRI acquisitions and pre-processing 
Segmentation was performed on each patients’ MRI data (DICOM files) using the Mimics 
inPrint 2.0 and Mimics research 20.0 software to create a 3D model of the heart. The heart 
toolkit enabled semi-automatic segmentation using a pre-defined 5-step workflow that allows 
specifying landmarks on the heart chambers and main arteries (aorta and pulmonary). It should 
be noted that the software is designed for a normal heart. Hence, for accurate recognition and 
extraction of the current conduit in the heart, knowledge of the anatomy and the ability to 
distinguish blood flow pathways in MRI 2D images from the user was required. The resulting 
3D model is generally satisfactory when the image data are of sufficiently high resolution. 
However, in this study, only archived imaging files were available, resulting in suboptimal 
resolution for semi-automatic segmentation. Hence, for all cases, manual modification of the 
heart regions and flow pathways on 2D images and interpolation between them were needed 
to ensure the accuracy of the model. Results of segmentation on data from 6 patients are shown 
in Figure 3.1. The models were checked by clinical colleagues for anatomical accuracy. At the 
end of segmentation process, various regions, namely right ventricle, left ventricle, right 
atrium, left atrium, aorta, pulmonary artery, and above all, RVOT including right ventricle, 
RV-PA conduit and pulmonary artery, were separated and saved in different files. This is 
important for the next step, which is geometry construction. 
3.3 Geometry construction 
The STL file generated from segmentation process includes the 3D model of each region in the 
heart. This file can be imported to ANSYS SpaceClaim for further analysis. However, this file 
in its original form is not useful for simulation purposes as it contains numerous segments that 
are not necessarily connected to each other smoothly. This will give rise to computational 
complexity and might lead to non-physical flows. Furthermore, including more details does 
not necessarily mean that the model is closer to the reality, as in the segmentation process, 
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these segments could have been mistakenly recognised as the blood pool due to low resolution 
or imperfect settings of thresholds. It should be noted that selection of threshold settings always 
encounters a trade-off between overgrown regions and improper extraction of the regions, due 
to imperfect resolution of the medical images.  
 
Figure 3.1 3D models of the patients’ hearts created by segmentation. Top: patients with PA/VSD, 
Bottom: patients with TA. Green: right atrium, fuchsia: left atrium, red: aorta, peach: left ventricle, 
purple + blue: RVOT including right ventricle, RV-PA conduit, right and left pulmonary arteries. 
RVOT is the region of interest in this study. Left atrium is mostly hidden from the perspective of the 
model shown in this Figure. 
Hence, it was necessary to make a simplified model of the conduit that utilises extract curves 
and has the correct dimensions, while being smooth and therefore appropriate for 
computational purposes. First, skin surface tools were tried, which also resulted in unnecessary 
details. Therefore, models were created by interpolating between several cross-sections (Figure 
3.2B) of the conduit extracted from segmented models. The resulting geometries were 
iteratively modified to replicate the original shape. The models created by this method could 
approximate the original conduit shape to a satisfactory degree, while being simple and 
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avoiding sharp changes as much as possible (Figure 3.2B). The geometry extraction process is 
demonstrated in Figure 3.2. The same approach was used to include the branches in the model. 
The aim was to compare the performance of the current implant with a proposed modified 
implant. Hence, a method of enhancing the geometry was needed. The first step was choosing 
a suitable diameter. The appropriate choice of the diameter of the implant conduit is based on 
weight, height, body surface area (BSA) measurements, age, and gender.  
 
Figure 3.2 The geometry construction process. (A) Constructing 3D model of the whole heart by 
performing segmentation on patients’ MRI. (B) Constructing conduit’s geometry by interpolating 
between extracted cross-sections. On the right: Extracting crucial cross-sections. On the left: The 
constructed geometry (green geometry) shows a satisfactory approximation of the original conduit 
shape obtained from segmentation (grey geometry). 
The diameter of the reconstructed mid pulmonary artery (MPA) can be an appropriate indicator 
of the diameter of the conduit. Using the method described in [96], the standard range for MPA 
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is calculated. Using the current diameter of MPA mentioned in MRI reports, its Z-Score is 
calculated. Z-score is a standardised value that indicates by how many standard deviations a 
value is above or below the mean in a normally distributed population. It is desirable that the 
Z-Score remains between –2 and 2. A Z-score above 2 or below -2 indicates too large or too 
small diameter, respectively. It should be noted that MPA cross-sections are mainly oval not 
perfect circles. Therefore, the equivalent diameter was introduced (𝐷𝐷𝑒𝑒𝑒𝑒  ) as the diameter of a 
circle that has the same area as the oval cross-section. When measurements vary in proximal 
and distal locations, the total 𝐷𝐷𝑒𝑒𝑒𝑒 is calculated by averaging proximal and distal 𝐷𝐷𝑒𝑒𝑒𝑒. The 
equations are shown below. 
Equation 3.1: 𝐷𝐷𝑒𝑒𝑒𝑒 of oval cross − section = √(major radius ×  minor radius) 
Equation 3.2: 𝐷𝐷𝑒𝑒𝑒𝑒 𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀 =  Proximal 𝐷𝐷𝑒𝑒𝑒𝑒 + Distal 𝐷𝐷𝑒𝑒𝑒𝑒 2  
The ultimate diameter of the modified geometry was then chosen considering two markers: the 
average of the proposed range using the method described in [97], and the current diameter of 
the conduit in the patient. The aim is to upsize the conduit commensurate with the patient’s 
growth. The proposed diameter is calculated as below: 
Equation 3.3: Proposed diameter =  3×(MPA interval average)+Current 𝐷𝐷𝑒𝑒𝑒𝑒 of MPA 
4
 
Also, with clinical guidance, the largest diameter that was chosen was 22 mm, even if the 
calculation led to a higher value, since larger diameter could be clinically problematic, due to 
the position of aorta and sternum. The details of the parameters used in calculations and 
proposed diameter for each patient is demonstrated in Table 3.2. The flow split displayed in 
Table 3.2 shows what fraction of the flow in the MPA goes towards the right pulmonary artery 
(RPA) and what fraction flows through the left pulmonary artery (LPA). This information is 
necessary when including the branches in the model.
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Table 3.2 Patient data used in diameter calculation 
 
The proposed method for choosing the appropriate diameter is not to be used without reviewing clinical data. For example, for patient F, the result 
of calculations suggested a conduit with a diameter of 13 mm, however, it was noted that this patient is only 3 years old, and since substantial 
somatic growth rate is expected, a diameter of 17 mm was proposed. 
Patient Height 
(cm) 
Weight 
(kg) 
BSA MPA or RV-PA 
diameter (mm) 
MPA 𝑫𝑫𝒆𝒆𝒆𝒆 
(mm) 
Flow Split 
𝑹𝑹𝑹𝑹𝑹𝑹 𝑳𝑳𝑹𝑹𝑹𝑹⁄  
Proposed MPA 
diameter range 
(mm) 
Z-score 
of MPA 
Proposed conduit 
diameter (mm) 
A 128 23.6 0.909 25×34 
 
29.2 8 92⁄  14.57-22.6 
 
4.25 22 
B 144 34 1.159 Proximal: 8×10 
Distal: 16×19 
 
13.2 80 20⁄  16.41-25.45 
 
–3.9 19 
C 153 49 1.445 23×29 
 
25.8 66 34⁄  18.28-28.35 
 
1.12 22 
D 126 25.4 0.940 Proximal: 9×10 
Distal: 13×18 
 
12.4 52 48⁄  14.81-22.97 
 
–3.54 18 
E 112 18 0.745 11×17 
 
13.7 64 36⁄  13.22-20.51 
 
–1.64 17 
F 84.3 11.4 0.521 9×11 
 
9.94 60 40⁄  11.1-17.21 
 
–2.98 17 
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After choosing the appropriate diameter, centre-line of the current conduit was extracted, and 
constant cross-section was lofted along it. This assists with removing sharp curves and angles 
that might result in high shear stress and energy loss, while ensuring the pathway is 
physiologically feasible and is not restricted by the location of other organs. An example of an 
initial conduit and its associated modified geometry is shown in Figure 3.3. 
 
Figure 3.3 An example of geometry modification. (A) initial conduit (B) proposed geometry. 
3.4 Simulation process 
A patch-conforming method was used to generate the surface mesh and 5 layers of inflation 
with a growth rate of 1.2 and maximum thickness of 2.5 mm were applied at the walls (Figure 
3.4). The target skewness was set to 0.6.  
Blood flow through the geometry was assumed to be a three-dimensional, time-dependent, 
incompressible, laminar flow [98]. A no slip boundary condition was assigned at the walls of 
the conduit, and the velocity profile was imposed at the inlet. The outlet was defined as an 
opening and the relative pressure at the outlet was set to zero.  
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The area averaged velocity at various cross-sections of the conduit over time is acquired from 
the echocardiograms of the patients (Figure 3.5) and is converted to the mass flow rate 
according to the cross-section at which it was measured. The velocity at the inlet is then set to 
yield the calculated mass flow rate. As the full velocity data over time were not accessible, it 
was necessary to estimate these data. To this end, the peak positive and negative velocity and 
the rising and falling durations were extracted. In first attempts, the velocity curve with a 
triangular wave as of Figure 3.6 was approximated.  
In this case, the sharp changes in the first derivative of the velocity (at peak velocities and the 
beginning and end of each cycle) is not physiological and causes computational instability. To 
address this problem, the triangular wave was approximated by the first n terms of its Fourier 
series to obtain a smoother velocity profile. The MATLAB code used for this purpose can be 
found in Appendix A. Figure 3.7 shows the triangular waveform estimated from 
echocardiogram of the test patient and the Fourier series approximations with various numbers 
of coefficients. As demonstrated, the difference between the curves with 𝑛𝑛 = 3, and 𝑛𝑛 = 4 is 
negligible. Hence, it sufficed to set 𝑛𝑛 = 3, which gives a 7 term Fourier series, that was used 
for the test case. The number of coefficients of Fourier series that was used for each patient 
varies. The rule of thumb is that the number of coefficients is increased until no significant 
change is noticed in two consecutive series.  
Lastly, output controls were set to monitor WSS and total pressure loss. As previously 
discussed, high WSS has been associated with luminal events and vessel instability in small 
vessels [72, 73]. Furthermore, the higher the energy loss, the more the ventricle needs to work 
to compensate for the loss of energy, which will be associated with hypertrophy and a higher 
oxygen consumption, and if not addressed, ultimately impairment of ventricular function. Total 
pressure loss is a good indicator of energy loss. Therefore, it is desirable to minimise WSS and 
total pressure loss. 
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Figure 3.4 An example of meshing on one of the geometries. 
 
 
Figure 3.5 Acquisition of velocity and pressure data from echocardiogram. 
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Figure 3.6 Demonstration of the parameters that define the velocity curve. 
 
Figure 3.7 Triangular velocity waveform and its Fourier series approximation for different number of 
terms. In this case, 𝒏𝒏 = 𝟑𝟑 provides sufficient accuracy. 
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3.5 Fluid domain 
3.5.1 Reynolds and Womersley numbers 
To justify the assumption of laminar flow, the Reynolds number (ℛ𝑒𝑒) for the geometries used 
in this study were calculated. This dimensionless quantity was obtained from Equation 3.4 for 
initial and modified geometries of each patient and the results are shown in Table 3.3. Laminar 
flow occurs when ℛ𝑒𝑒 < 2300 and turbulent flow happens above this. The results in Table 3.3 
shows that the Reynolds numbers are below 2300, hence, the assumption of laminar flow is 
valid for the cases investigated in this study. 
Equation 3.4: ℛ𝑒𝑒 =  𝜌𝜌𝜌𝜌𝜌𝜌
𝜇𝜇
 
where 𝜌𝜌 is the density of the blood, 𝑢𝑢 is the average velocity of the fluid, L is a characteristic 
dimension, which here is the diameter of the conduit, and 𝜇𝜇 is the dynamic viscosity of the 
fluid. 
Table 3.3 Reynolds number for geometries included in this study 
Patient 𝓡𝓡𝒆𝒆 for initial geometries 𝓡𝓡𝒆𝒆 for modified geometries 
A 2213 1534 
B 1351 1538 
C 1799 897 
D 2033 2125 
E 252 150 
F 600 1139 
 
Womersley number (𝛼𝛼) is another dimensionless number that characterises a flow system. It 
determines the ratio of the maximum flow developed for a given oscillating pressure to the 
corresponding steady flow, and the phase lag between the applied pressure and the flow [99]. 
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In practice, similar magnitude of Womersley number for a given geometry in experimental 
studies and the patient guarantees kinematic similarity of the flow. The Womersley number 
determines the form of the flow, but not the magnitude.  
The Womersley number was also estimated for all the geometries used in this study using 
Equation 3.5. The results shown in Table 3.4 show high Womersley numbers (more than 10) 
for most cases. High Womersley numbers mean that the frequency of the pulsatile flow is too 
large to allow parabolic velocity profile to be developed over a cycle. Instead, the velocity 
profile is relatively flat. 
Equation 3.5: 𝛼𝛼 = 𝐿𝐿 �𝜔𝜔𝜌𝜌
𝜇𝜇
�
1
2  
where 𝐿𝐿 is the diameter of the conduit, 𝜔𝜔 is the frequency of the oscillations, 𝜌𝜌 is the density 
and 𝜇𝜇 is the dynamic viscosity of the blood. 
 
Table 3.4 Womersley number for geometries included in this study 
Patient 𝜶𝜶 for initial geometries 𝜶𝜶 for modified geometries 
A 19.95 15.03 
B 8.95 12.89 
C 16.4 13.99 
D 8.13 11.8 
E 9.56 11.87 
F 7.93 13.57 
 
3.5.2 Effect of viscosity model 
As mentioned before, while a Newtonian model assumes a linear relationship between the 
applied stress and the rate of strain of blood, non-Newtonian models take into account the 
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changes happening to the viscosity with shear rate. Although in reality the viscosity is not 
constant, in section 2.5.1, it was concluded that the significance of employing a non-Newtonian 
blood model on the simulation results is case dependent. Hence, both a Newtonian and a non-
Newtonian blood model were tested for the case of RV-PA conduit to understand the effects 
of viscosity models on the results. In the case of a Newtonian model a density of 1060 kg m-3 
and dynamic viscosity of 0.0035 Pa s [6] was applied. However, it is possibly too simplistic to 
assume that the blood viscosity is constant, as it varies with the shear rate. To model the non-
Newtonian behaviour of the blood, the Carreau-Yasuda model is employed [100]. 
Equation 3.6: 𝜇𝜇(?̇?𝛾) = 𝜇𝜇∞ + (𝜇𝜇0 − 𝜇𝜇∞)[1 + (𝜆𝜆?̇?𝛾)𝑎𝑎](𝑛𝑛−1) 𝑎𝑎�  
where 𝜇𝜇 is the dynamic viscosity, 𝜆𝜆 is a time constant, n is the power law index, a is the Yasuda 
exponent, ?̇?𝛾 represents a scalar measure of the rate of deformation or so-called shear rate, and 
𝜇𝜇0 and 𝜇𝜇∞ denote the viscosity at zero and infinity shear rate, respectively. These parameters 
have been experimentally obtained to be: 𝜇𝜇0 = 0.056 Pa s, 𝜇𝜇∞ = 0.00345 Pa s, 𝜆𝜆 = 1.902 s, 
𝑛𝑛 = 0.22, 𝑎𝑎 = 1.25 [36]. 
For the test case considered here (patient E), no significant discrepancies were noticed between 
total pressure loss and tangential forces for the Newtonian and non-Newtonian blood model. 
This means that the changes in the simulation in the case of RV-PA conduit are insignificant, 
and Newtonian models are sufficient for capturing accurate outputs. However, for 
completeness, the non-Newtonian model was applied for the remainder of the study. Results 
of this test are shown in Figures 3.8 and 3.9. Since the water and blood have similar densities 
and different viscosities, the large difference between the results of water and blood models 
shows the effect of the liquid viscosity on pressure loss and tangential forces. Hence, the 
accuracy of determining the viscosity value is important.  
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The reason for choosing patient E as the test case was the geometrical complexity of the 
implanted RV-PA conduit. It is assumed that if the mesh and time-step independence are 
demonstrated for this case, they will be valid for the simpler geometries. 
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Figure 3.8 Total pressure loss over a cardiac cycle for water and Newtonian and non-Newtonian 
blood model.  
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Figure 3.9 Magnitude of tangential force on conduit over a cardiac cycle for water and Newtonian 
and non-Newtonian blood model. 
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3.6 Mesh and time-step independence validation 
In order to confirm mesh-independence of the simulation results, three element sizes were used, 
namely 2, 1.5 and 1 mm. The following parameters over a cardiac cycle were monitored: 
tangential forces and total pressure loss through the conduit. Figures 3.10 - 3.12 show that total 
pressure loss, the magnitude of the tangential force, and WSS on the conduit are very close 
regardless of the mesh size. Hence, mesh-independence can be concluded. Based on this study 
an element size of 1.5 mm was selected. 
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Figure 3.10 Total pressure loss over the conduit over a cardiac cycle resulting from different mesh 
element sizes. 
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Figure 3.11 Magnitude of tangential force on the conduit over a cardiac cycle resulting from different 
mesh element sizes. 
 
Figure 3.12 Maximum wall shear stress on the conduit over a cardiac cycle resulting from different 
mesh element sizes. 
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In addition to mesh-independence, time-step independence of the results needs to be 
established to ensure the computational validity of the results. To this end, with the mesh size 
of 1.5 mm that was obtained from the mesh-independence test, simulations were performed 
using varying time steps of 0.5, 1 and 2 ms. In order to confirm that all the simulations lead to 
same results, the same parameters as for mesh-independence test were monitored: tangential 
forces on the walls and total pressure loss through the conduit over a cardiac cycle. In all cases, 
the second cardiac cycle, which for the test case is from 0.68-1.36 s is demonstrated. This is 
due to the fact that at the beginning of the first cycle of the simulation, some instability in the 
results is always noticed at start-up. From Figures 3.13 and 3.14 it can be seen that there is no 
significant change in the abovementioned output monitors for selected time-step sizes. 
Therefore, time-step independence can be concluded, and from here on a time-step size of 1 ms 
is selected for all simulations. 
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Figure 3.13 Total pressure loss over the conduit over a cardiac cycle resulting from different time-
step sizes. 
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Figure 3.14 Magnitude of tangential force on the conduit over a cardiac cycle resulting from different 
time-step sizes. 
3.7 Methods to compare the efficacy of different geometries 
3.7.1 Wall shear and pressure loss 
As the aim is to compare the performance of an initial clinically-used conduit with a proposed 
modified implant, the WSS and total pressure loss over the conduit were determined. The 
importance of minimising WSS was elaborated upon in Section 2.7. Total pressure loss is 
indictive of energy loss when the mass flow rate does not change. In this study, it was assumed 
that the mass flow rate does not change before and after the surgery. This is a reasonable 
assumption, since the mass flow rate depends on the volumetric capacity of the right ventricle, 
which is determined by physiological characteristics of the patients and is unlikely to change. 
The mass flow rate profile before surgery is obtained by multiplying the velocity profile 
obtained from the echocardiograms of the patients, by the cross-sectional area at which the 
velocity was measured, by density (Equation 3.7).  
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Equation 3.7: ?̇?𝑚 =  𝜌𝜌 . ?̇?𝑉 =  𝜌𝜌 . 𝑣𝑣.𝑀𝑀  
where ?̇?𝑚 is the mass flow rate, ?̇?𝑉 is the volume flow rate, 𝑣𝑣 is the flow velocity of the mass 
elements, and A is the cross-sectional area. The velocity at the inlet for the initial and modified 
geometries is then set accordingly to yield the calculated mass flow. In cases where the exact 
location of the velocity measurement is not specified, it is sensible to define an indicative cross-
sectional area by averaging several cross-sectional areas over the conduit.  
With these considerations, area-averaged WSS on conduit wall and total pressure loss 
throughout the conduit over a cardiac cycle for initial and modified geometries were monitored 
and compared. It was necessary to introduce a metric to measure the scale of the changes of 
WSS. The effective wall shear on the conduit wall in one second per unit area was calculated 
using the equation below: 
Equation 3.8: Effective 𝑊𝑊𝑊𝑊𝑊𝑊 = ∫ 𝑊𝑊𝑊𝑊𝑊𝑊𝐴𝐴𝐴𝐴𝑒𝑒 𝑑𝑑𝐸𝐸 𝜏𝜏
𝜏𝜏
 
where 𝑊𝑊𝑊𝑊𝑊𝑊𝐴𝐴𝐴𝐴𝑒𝑒 is the area-averaged WSS and 𝜏𝜏 is the period of the cardiac cycle. This equation 
gives the time and area averaged WSS over a cardiac cycle. 
3.7.2 Energy dissipation 
In clinical settings, non-computational fluid dynamics options merely allow evaluation of 
ventricular volumes, flow, and pressure. Even these data are only available on specifically 
chosen planes, as opposed to the whole volume and their acquisition might require invasive 
procedures. CFD allows energy-based metrics for assessment of ventricular haemodynamic 
performance. Energy-based metrics such as energy loss and ventricular stroke work (SW) and 
efficiency, can integrate several haemodynamic indicators, for instance pulmonary flow and 
pressure data into a single parameter.  
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Fewer studies have focused on utilising computational models for performance evaluation of 
the right heart as it was considered less critical for patients’ health. However, extra RV work 
as a result of conduit dysfunction (stenosis and/or regurgitation) may in turn lead to RV 
hypertrophy and/or dilation and progressive RV dysfunction [101, 102]. Hence, providing a 
metric for assessing the energy efficiency of the proposed conduit is necessary. Mechanical 
energy dissipation rate was selected as an energy-based metric for comparison of initial and 
modified geometries’ performance. The derivation of the expression for mechanical energy 
dissipation is detailed in Appendix B. Since patients have different periods of cardiac cycle, 
for comparison, the rate of energy dissipation per second was then obtained by dividing the 
total energy dissipation over a cardiac cycle by the period. 
Simulations were performed using the methods described in this chapter and the results are 
presented in the next chapter. 
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4 Results and discussion 
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4.1 Geometry modification results 
Using the methodology described in Section 3.3, the current clinically-used conduit geometry 
was extracted, and a modified geometry was proposed for each of the six patients. The results 
are shown in Figure 4.1A-4.1F. 
 
 Page | 58 
 
 
Figure 4.1 Clinically used conduits (left) and proposed modified geometries (right) for patients A-F. 
4.2 Flow results 
Typical flow (at the beginning of a cardiac cycle) through the initial and modified conduit 
geometries is shown in Figure 4.2. It is evident from the figure that the flow through the 
modified geometries is improved as it is more streamlined and has lower velocities. Enlarging 
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the diameter of the conduit has resulted in lower velocities. Smoothing the sharp curves has 
reduced or eliminated the circulating flow. This can be seen clearly in patients A and D. 
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Figure 4.2 Flow through clinically-used conduits (left) and proposed modified geometries (right) for 
patients A-F. 
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4.3 Qualitative simulation results 
The aim of this section is to compare the performance of the current RV-PA conduits in 
patient’s body with a proposed modified conduit to be used for its replacement. The hypothesis 
was that upsizing the conduit and smoothing the sharp curves and angles would improve the 
performance indices, such as total pressure loss and WSS.  
The results shown in Figures 4.3-4.8 suggest qualitatively that the implant modification 
assisted in decreasing the WSS and total pressure loss for all six patients. In all cases, the 
simulations were performed for 3 cycles to allow stable results, and the results are shown for 
the first cycle that shows no noticeable change from the previous one.  
The changes in total pressure loss are more noticeable than WSS. The reason for this is that 
upsizing the conduit reduces the velocity substantially, and this has a direct effect on pressure 
loss. However, multiple factors affect WSS.  
WSS changes proportionate to the amount of tangential forces caused by the flow affecting the 
wall regardless of their direction, hence in the Figures, two peaks are noticed for WSS at points 
which maximum inward and outward flow happens.  
For patient F, it was noticed that different results were produced from those of other patients 
(Figure 4.8). The first proposed modification of the geometry with the diameter of 17 mm, 
increased the total pressure loss and area-averaged WSS in contradiction with expectations. 
Hence, a second modification of the geometry was proposed using the same curves and angles 
but with an enlarged diameter of 19 mm. This time, similar results to other patients were 
observed in accordance with expectations.  
This case accentuates the crucial influence of the diameter of the conduit on important 
haemodynamic factors. In addition, it underscores the importance of patient-specific modelling 
in design of the modified implant. Here, the hypothesised appropriate diameter did not enhance 
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the performance of the implant, hence, a second geometry was proposed to resolve this issue. 
This was impossible to foresee without the employment of a patient-specific model. Lastly, 3D 
model of the heart ensures that patient’s anatomy is capable of accommodating the proposed 
conduit geometry. 
It is evident from the following figures that smoothening and upsizing the conduit geometries 
decreased the total pressure loss and WSS, hence improved their performance. 
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Figure 4.3 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient A. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle.  
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Figure 4.4 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient B. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle. 
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Figure 4.5 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient C. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle. 
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Figure 4.6 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient D. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle. 
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Figure 4.7 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient E. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle. 
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Figure 4.8 Comparison of haemodynamic parameters through the initial implant and proposed modified 
geometry for patient F. Total pressure loss over the conduit (top) and area-averaged WSS on the conduit 
(bottom) are shown for a cardiac cycle. 
Figure 4.9 (A-F) illustrates typical distributions of WSS at the beginning of a cardiac cycle for 
the initial and modified conduit geometries for all patients. The decrease in WSS in modified 
geometries is also apparent here. 
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Figure 4.9 Comparison of WSS distribution between initial (left) and modified geometries (right) for 
patients A-F. 
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4.4 Quantitative analysis 
The values of Effective WSS and energy dissipation as described in section 3.7 were calculated 
for the initial and modified geometries for each patient. Results are summarised in Table 4.1. 
Table 4.2 gives the improvement of these parameters for the modified geometries compared 
with the initial geometries as a percentage.  
Table 4.1 Comparison of Effective WSS and energy dissipation for initial and modified geometries for 
all six patients. 
Patient 𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄 𝐖𝐖𝐖𝐖𝐖𝐖 
on initial 
geometry (Pa) 
𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄 𝐖𝐖𝐖𝐖𝐖𝐖 
on modified 
geometry (Pa) 
Rate of energy 
dissipation in initial 
geometry (W) 
Rate of Energy 
dissipation of modified 
geometry (W) 
A 13.39 9.97 5.13 0.650 
B 13.46 9.41 1.92 1.07 
C 12.8 7.26 1.99 0.423 
D 14.93 9.54 1.65 0.977 
E 9.2 4.03 0.247 0.078 
F 13.02 10.58 1.54 1.17 
 
Table 4.2 Improvement in Effective WSS and energy dissipation for modified geometries compared 
with initial geometries in percentage for all six patients. 
Patient Decrease in 
𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄 𝐖𝐖𝐖𝐖𝐖𝐖 (%) Decrease in energy dissipation (%) 
A 25 87 
B 30 44 
C 43 78 
D 36 40 
E 56 68 
F 18 24 
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From Table 4.2 it can be seen that the geometry modification process resulted in up to 56% 
decrease in the effective wall shear and decreased the mechanical energy dissipation through 
the conduit by up to 87%. These results suggest that if the proposed design of the implant is to 
be 3D printed and utilised in the surgery to replace the current implant, it is likely to improve 
the procedure outcome from a fluid dynamics perspective. The most conspicuous benefits of 
the proposed method would be reduced structural deterioration as a result of reduced WSS 
which may enhance durability of the conduit. Improvements in energy loss may also translate 
to improvements in right ventricular performance over time although that has not been tested 
in our model or by others. 3D printing the proposed conduit will ensure that the anatomy of the 
patient can accommodate the design, hence eliminating the need for modifications, such as 
using an additional hood, through the surgery.  
In addition, in Appendix C, the performance of the modified geometries is benchmarked 
against three variations of straight pipes. 
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5 Computational modelling in material 
assessment 
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5.1 Chapter overview 
Current off-the-shelf solutions for RV-PA conduit material involve the use of human or animal 
tissue which fail rapidly and do not grow with the young patient [103, 104]. Therefore, there is 
an urgent need to develop an alternative implant for vascular conduit that mimic innate tissue. 
Supramolecular elastomers are appealing materials for fabrication of tissue engineered vascular 
grafts as such implants mimic the mechanical properties of human arteries. However, 
elastomeric biodegradable scaffolds have yet to gain wide clinical use. 
Computational modelling has a role to play in development of more efficient RV-PA conduits. 
It can expedite the design optimisation process in tissue engineering by predicting structural 
mechanics and eliminating the need for mechanical testing at the trial-and-error stages. In this 
section, this functionality of computational modelling is employed to determine the 
performance of a biodegradable elastomer developed by our research group. The development, 
synthesis and mechanical testing of the material was performed by other team members [105], 
and the contribution of this author is the computational modelling and simulations that are 
further described in this chapter. 
5.2 Introduction 
Tissue engineering is an emerging field that may address the ever-increasing demand for in 
vitro engineered tissue [106, 107]. Biodegradable polymers provide the convenience of 
prosthetics with the functionality of homograft, producing a broadly available therapy for 
paediatric patients [108]. Bioresorbable polymeric valved tubes have been deployed in human 
trials by commercial teams such as Xeltis (ClinicalTrials.gov identifier NCT03022708), TEH-
Tube program (https://www.teh-tube.eu) and research groups such as those led by Shinoka 
[109, 110]. Aliphatic biodegradable polyesters, such as polyglycolic acid and polylactic acid 
are the dominant composition in the reconstruction of their RV-PA conduit [111, 112]. Clinical 
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concerns include variable scaffold degradation rate (influencing ‘growth’ and structural 
integrity), and development of local inflammation causing stenosis (narrowing of the conduit), 
possibly because of accumulation of toxic by-products or generation of low pH micro-
environments, as shown previously [113, 114]. 
Poly (propylene carbonate) (PPC) is a copolymer that degrades into benign products of water, 
and carbon dioxide. It is hypothesised that PPC with biologically neutral degradation products 
can eradicate the associated risks with conventional biodegradable synthetic polymers [113]. 
However, the mechanical performance of PPC is not within the acceptable range for vascular 
applications [115]. Physical blending or chemical modifications of PPC is a convenient method 
to improve the polymer’s limitations. For instance, a copolymer of PPC and poly(caprolactone) 
(PCL) was developed by Spoljaric et al. via an efficient one-pot, two-step method with superior 
toughness and biodegradation properties [116]. PCL has been successfully used to tune the 
mechanical properties of poly(lactic acid) (PLA) and to establish biodegradation in various 
polyurethane (PU) systems [117-120]. For vascular tissue engineering, a biodegradable PU 
with tuneable mechanical properties is favourable with an appropriate functional end group, 
such as NCO terminated PU without using any toxic catalyst [121, 122]. Therefore, it was 
speculated that a tri-block copolymer consisting of PPC, PCL and PU could be a promising 
biomaterial for fabricating biodegradable implants that mimic the natural structure of 
pulmonary artery. 
Hence, PPC-PCL-PU was synthesised by our team members and its suitability for RV-PA 
implant construction was investigated by characterising its mechanical and biological 
performances. A one-pot catalyst-free chemical reaction comprising polycondensation 
followed by esterification was used for synthesis of this triblock copolymer with the NCO-
terminated groups. In vitro assays using human endothelial cells confirmed survival, 
proliferation, and exertion of angiogenesis properties. A subcutaneous implantation mice 
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model demonstrated the biocompatibility of the synthetic elastomer. These findings support 
the utility of this triblock copolymer for tissue engineering pulmonary arteries. Herein, the 
application of computational modelling for in situ evaluation of the synthesised material 
performed by the author is described. 
The conduit structure was modelled to compare the performance of the synthetic material with 
that of the original material in similar conditions using computer simulations, which also 
allowed the determination of appropriate dimensions of the synthetic material to mimic the 
behaviour of a homograft pulmonary wall. The material with the optimised dimensions 
obtained from simulations was then synthesised [105]. The results of mechanical testing on 
this material showed similar properties to that predicted from simulations. Computer 
simulations had the advantage of being less time and cost consuming than laboratory and 
animal experiments. 
5.3 Application of computational modelling in tuning mechanical 
properties of the synthesised material to achieve optimal results 
5.3.1 Initial mechanical tests 
In re-creation of the pulmonary artery, it is critical to design a material with similar mechanical 
and surface properties. A stiffer and less elastic structure can cause deterioration, calcification, 
and stenosis when used in cardiovascular applications [123, 124]. The design of the triblock 
copolymer was initially guided by the measurement and analysis of a human pulmonary artery 
wall (Figure 5.1A to 5.1D).  
The human pulmonary artery wall and the invented material were tested mechanically using an 
Instron (model 5543) with a 1000 N load cell [117]. The elongation (mm) and load (N) were 
obtained at a crosshead speed of 30 μm/s and up to 0.5 mm/mm of strain level. The ultimate 
tensile strength, tensile modulus, and elongation at break were then calculated using 
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stress−strain curves and the linear strain region of 0.1 to 0.2 mm/mm. The mechanical 
properties of both pulmonary artery wall and synthetic materials are given in Table 5.1.  
 
Figure 5.1 Mechanical properties. (A) and (B) a pulmonary artery sourced from human cadaverous 
tissue; (C) tensile testing of the homograft tissue; and (D) tensile testing of the tri-block copolymer. 
Table 5.1 A summary of the mechanical performances of the pulmonary artery wall and synthetic 
polymers at different steps [117]. 
Sample Tensile modulus 
(MPa) 
Ultimate tensile 
strength (MPa) 
Elongation at 
break (%) 
Pulmonary artery wall 1.69 ± 0.36 0.71 ± 0.08 73 ± 0.85 
PPC 17.12 ± 0.89 6.65 ± 1.01 8.6 ± 1.8 
PPC-PL 13.87 ± 0.97 3 ± 0.14 14 ± 0.71 
PPC-PL-PU 0.61 ± 0.12 0.69 ± 0.02 880 ± 24.3 
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The tensile test showed that the ultimate strength and elongation at break of the homograft 
tissue are 0.71 ± 0.08 MPa and 73 ± 0.85 %, while the sample possessed a tensile modulus of 
1.69 ± 0.36 MPa (Table 5.1). These values for PPC as the primary material were 17.12 ± 0.89 
MPa, 8.6 ± 1.8 % and 6.65 ± 1.01 MPa, respectively. The chemical modification of PPC using 
PCL and PU led to the formation of a synthetic structure that mimics the mechanical properties 
of the human pulmonary artery wall. The tensile modulus and ultimate tensile strength of the 
biodegradable polymer dropped to 0.61 ± 0.12 and 0.69 ± 0.02 MPa with a significantly higher 
elongation at break at 880 ± 24.3 %. These values were measured for a polymer sheet 0.1 mm 
in thickness. All the results are reported as mean ± SD acquired from at least three independent 
experiments at each condition. Statistical analysis (N = 3) was performed using a one-way 
analysis of variance (ANOVA) with a Tukey’s multiple comparisons tests for a significance 
level of p < 0.05. 
5.3.2 Modelling and Simulation 
Both physicochemical properties and the thickness of the material have impacts on mechanical 
strength and function of materials used for the construction of a valvular conduit. Therefore, 
structural analysis was used to predict the optimised thickness of a conduit made from materials 
developed to reduce the risk of failure. To this end, the deformation of the innate conduit under 
the maximum arterial pressure of 16.6 kPa (125 mmHg) was set as a reference (Figure 5.3A) 
and compared with the deformation of the conduit made from synthesised material with varying 
thicknesses ranging from 0.1 to 1.4 mm (Figure 5.3B to 5.3E). The objective was to ensure the 
synthetic material mimics the innate tissue and remains durable in physiological conditions. 
The lower deformation at the maximum pressure endorse stability of the materials. 
Static structural analysis was performed using ANSYS Mechanical V19 to compare the 
behaviour of innate tissue and synthetic polymer and to predict the optimised thickness of the 
polymer. To this end, a cylindrical geometry was considered in the modelling with length of 
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50 mm and inner diameter of 15 mm that was estimated based on the average size of common 
implants for children (12-18 mm). The geometry was constructed using ANSYS SpaceClaim 
and meshed with shell elements (Figure 5.2). The mechanical properties of the innate material 
and the synthesised tissue were then imposed on the model. The Young’s modulus was 
measured using an Instron, while the densities were measure using conventional Archimedes 
method [105]. The Poisson’s ratio value (0.5) was adopted from [125]. The maximum arterial 
pressure in the region of interest, which is 125 mmHg (16.6 kPa), was applied uniformly on 
the inner surface of the conduit. Therefore, the maximum deformation on the wall of conduit 
can be measured to reduce the risk of failure. Fixed supports were applied at both ends, which 
results in maximum deformations and satisfies the objectives of replicating the original 
material behaviour. Furthermore, the wall material was assumed to have linear characteristics 
in both cases. In this study, the length and diameter for cryopreserved human pulmonary artery 
and synthetic material were constant at 50 and 15 mm, respectively. The wall thickness for the 
pulmonary artery was kept constant at 0.5 mm, while this value for synthetic material was 
variable. 
 
Figure 5.2 Shell element mesh for the simplified conduit geometry. 
The maximum arterial pressure in physiological condition for the region of interest is 16.6 kPa. 
As shown in Figure 5.3A, the maximum deformation of the native conduit material for an 
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internal pressure of 16.6 kPa was 1.1 mm. The simulation of the synthetic material with a 
thickness of 0.1 mm under this pressure led to high deformations that prevented model 
convergence (data not shown). It means that under these boundary conditions, the synthetic 
material does not replicate the functionality of innate conduit tissue. For the synthetic material 
it was desirable to avoid conditions that deformation was 5-fold greater than 1.1 mm (e.g. 
5.5 mm deformation). The thickness of the synthetic material and the applied internal pressure 
of the conduit were then manipulated to satisfy this condition. In the following numerical 
experiments, it was assumed that the Young’s modulus was independent of the thickness. 
Simulations were conducted on the synthetic material with the initial thickness at lower 
pressures. The maximum pressure that resulted in less than 5.5 mm was 2.2 kPa (Figure 5.3B). 
This was only 13% of the maximum pressure and demonstrated that the deformations for the 
synthetic polymer were higher compared with the innate tissue under the maximum pressure. 
Hence, material performance had to be improved in terms of durability. It was hypothesised 
that increasing the thickness of the synthetic material might decrease the deformation. To this 
end, in the simulation the maximum pressure (16.6 kPa) was applied while the thickness of the 
polymer was gradually increased until similar behaviour to that of the innate tissue was 
achieved at a thickness of 1.3 mm (Figure 5.3C). The thickness of the synthetic material was 
then increased further to 1.4 mm, and this produced a 10% reduction in deformation (Figure 
5.3D). Results of a simulation of the synthetic material with 0.5 mm thickness, the same 
thickness as the native conduit material, is displayed in Figure 5.3E. The maximum pressure 
that resulted in the desirable deformation as described before was 9 kPa, which is nearly half 
of the maximum pressure in the conduit. It was observed that the total deformation was still 
higher than the innate tissue for the maximum pressure of 16.6 kPa (Figure 5.3A). Therefore, 
increasing the thickness of the synthetic material to 1.4 mm was deemed likely to replicate the 
native tissue’s behaviour. 
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The mechanical properties of the PCL-PPC-PU materials after increasing the thickness to 
1.4 mm showed similar behaviour in tensile modulus to the native pulmonary artery. The 
tensile modulus was elevated to 1.43 ± 0.78 MPa, while the ultimate strength and elongation 
at break remained constant. Therefore, the deformation behaviour of the PCL-PPC-PU under 
the maximum physiological conditions followed the same pattern as the normal pulmonary 
artery.  
 
Figure 5.3 Structural analysis to compare the behavior of native tissue with the synthetic material with 
various thicknesses. (A) deformation of the original conduit for an internal pressure of 16.6 kPa; (B) 
deformation of the synthetic material with initial thickness of 0.1 mm for an internal pressure of 2.2 
kPa; (C) deformation of the synthetic material with thickness of 1.3 mm for an internal pressure of 16.6 
kPa; the minimum thickness of the synthetic material required to behave similar to the original tissue 
under the maximum pressure; (D) deformation of the synthetic material with thickness of 1.4 mm for 
an internal pressure of 16.6 kPa; increasing the thickness to 1.4 mm leads to even more conservative 
option; (E) deformation of the synthetic material with thickness of 0.5 mm for an internal pressure of 9 
kPa. 
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5.4 Structural analysis of initial and modified geometries 
In this section, the structural analysis was extended to the initial and modified geometries of 
each patient to compare their deformations and equivalent stresses. Here, instead of applying 
the maximum arterial pressure with a uniform distribution, the pressures resulting from CFD 
simulations are imported as loads, which creates a more realistic load condition. Fixed supports 
are applied at both ends of the conduit. An automatic thin sweep mesh method with solid shell 
elements is employed. The meshing for current clinically-used conduit for patient E is shown 
in Figure 5.4. To demonstrate the influence of the geometry modification, it is assumed that 
the same material as the current clinically-used conduit will be used for the proposed modified 
conduit. The mechanical properties of this material are selected to replicate the pulmonary 
human artery wall (Table 5.1). Total deformation and equivalent (von-Mises) stress at the 
beginning of a cardiac cycle, which shows a typical time, are calculated and shown in Figure 
5.5 and 5.6. A significant reduction of these parameters for all modified geometries is evident 
from these figures. This reconfirms the conclusions made in the previous chapter. 
 
Figure 5.4 Automatic thin sweep mesh method demonstrated on initial conduit of patient E. 
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Figure 5.5 Comparison of the equivalent stress on conduit’s wall between initial (left) and modified 
geometries (right) for patients A-F. 
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Figure 5.6 Comparison of the conduit’s wall deformation between initial (left) and modified 
geometries (right) for patients A-F. 
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5.5 Conclusions 
Finite Element Analysis (FEA) simulations allowed prediction of the mechanical behaviour 
and to obtain the optimised thickness of the material without the need to produce it at each step. 
Simulations minimise the time and lower the cost as the parameters could be altered instantly 
and the results of each step were produced rapidly, compared with experimental trial and error. 
One-way fluid structure analysis of the initial and modified geometries showed reduced total 
deformations and equivalent stresses for modified geometries. Therefore, it reconfirmed that 
the performance of the implant was improved in all cases. 
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6 Conclusions and future direction 
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This work was aimed to develop a methodology for patient-specific optimisation of the 
geometrical design of the RV-PA implant and to utilise computational modelling to expedite 
the material design process. Proof of concept is provided that can be extended in the future 
with ultimate goal of 3D printing customised conduits for each patient to be used during 
replacement surgery or percutaneous implantation. 
Integration of clinical data with engineering techniques allowed construction of patient-specific 
models that can be used for optimisation of the geometrical design of the implant. Patient-
specific models were constructed using the clinical data, and CFD analysis was employed for 
design modification. Structural analysis was also utilised to evaluate the performance and to 
optimise the dimensions of a tissue engineered material. 
A methodology for extracting implant’s geometry from segmented medical images of the heart 
was successfully developed. A strategy for modifying the geometrical design of the implant 
considering the anatomy and clinical data of patients was advanced. Models of the initial 
clinically-used implants and proposed modified implants were constructed and suitable 
boundary conditions were applied.  
Simulation of blood flow through the initial and modified geometries showed significant 
improvements in flow patterns, total pressure loss, WSS, and mechanical energy dissipation 
for the modified geometries. It was demonstrated that flow was more streamlined, and the total 
pressure loss was reduced through the modified geometries. Average WSS on the conduit wall 
was reduced by between 25-56 % and mechanical energy dissipation rate was reduced by 
between 24-87 % in the modified geometries for patients A-F. Hence, the goal of designing a 
patient-specific haemodynamically improved implant was realised.  
The patients were selected to be a representative spread of pathologies and conduit types. 
Hence, it is predicted that the proposed method would result in haemodynamic improvement 
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for most cases. However, the scale of improvement cannot be directly extrapolated to the wider 
population of patients with RV-PA connections as yet, due to a large inter-patient variability. 
With current approaches, replacement of RV-PA conduits is unavoidable for patients with a 
reconstructed RVOT. The underlying factors that necessitate the replacement of the conduit 
include valve incompetence, regurgitation, stenosis, and above all conduit obstruction. It is 
intuitive that all these attributes contribute to mechanical energy loss. Hence, the methodology 
developed for evaluation of energy dissipation over the conduit could, in the future, be 
employed to calculate an index of energy loss, as an aide in the monitoring of patients with a 
conduit and to guide the timing of replacement.  
Currently, the indication of re-operation is based on echocardiography measurements of RV to 
PA pressure gradient (pressure gradient over the conduit), or the ratio of right ventricular 
systolic pressure to left ventricular systolic pressure [126]. These are all subjective and 
sometimes not easily replicated between observers, and echocardiography windows can be 
poor for some patients. An index of energy loss might be very useful clinically, since it 
incorporates all the elements that combine to produce conduit failure. If serial MRIs were done, 
an index of energy low could guide timing of reoperation before the development of right 
ventricular failure, since symptoms of excessive RV work appear late and are usually non-
specific, for instance, tiredness and exercise intolerance. 
The models constructed in this study can be improved by including turbulence in blood models 
in geometries with higher Reynolds numbers (patients A, C, D). Effects of suture lines on the 
haemodynamics can also be studied. Including pulmonary artery branches in the model can be 
done as an extension to this study, which is predicted to have a significant effect on the results 
of energy dissipation and stress distribution. Moreover, the effect of the valve on the flow, 
energy dissipation, and WSS distribution needs to be investigated.  
 Page | 87 
 
In addition to the conduit design, computational modelling can play a significant role in valve 
design – an important aspect of conduit design that has not been covered by this work. Valve 
competence is an important clinical outcome and clinical experience suggests that homografts 
– in particular – often develop regurgitation within weeks to months of implantation. 
Potentially, models can be constructed to compare the behaviour of a proposed design (with a 
proposed material) with a normal human valve.  
Validation of the simulation results against clinical data is necessary. Velocities and pressures 
at several points in the conduit can be compared with MR or echocardiography measurements 
to ensure the accuracy of the results. An inherent limitation of this study is the use of pre-
operative boundary conditions for evaluating the performance of a proposed modified implant. 
Hence, prospective paired analyses of conduit performance before and after replacement is 
needed to validate the conclusions. Correlation of non-invasive assumed values with invasively 
measured data in a subset of patients and/or animal models can also be investigated. 
As an extension to this study, employment of modern geometric modelling techniques such as 
iso-contouring that are the basis of Iso-Geometric analysis [127] can be investigated for patient-
specific modelling of RV-PA conduit. Iso-Geometric analysis can be a valuable tool in 
modelling deforming geometries such as valves since mesh refinements can be performed 
automatically in this method. These methods enhance the accuracy of geometric acquisition 
and may be a first step towards automating the performance assessment and design process of 
RV-PA valved conduits. This would have the potential to be included in post-operative 
monitoring and management paradigm of these patients. 
In this study, haemodynamical improvement of a proposed modification of a current clinically 
used conduit was demonstrated. As a test of concept, the ‘ideal’ geometry can be 3D printed 
for temporary placement intraoperatively, to confirm that design fits and is appropriate, after 
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removal of the existing conduit and before placement of the new homograft or xenograft. This 
may assist in modification of the described techniques. For example, currently the modified 
geometry was lofted along the centreline of the current conduit. This is not the only design that 
is feasible, the performance of several independent geometrical designs for each patient can 
also be studied and compared in the future.  
In addition to customisation of the geometrical design of the implant, computational modelling 
was used to compare the behaviour of a synthetic material with innate pulmonary wall tissue 
under the maximum arterial pressure. Accordingly, structural analysis was used to predict the 
appropriate thickness of the synthetic material to replicate the stiffness of the innate tissue. The 
synthesised material with the proposed thickness showed similar mechanical properties to 
pulmonary wall tissue. This method helped expediting the material design process by 
eliminating the need for unnecessary in vivo assessments. The comparison of the performance 
of the initial and modified geometries using structural analysis, with pressure distributions from 
the CFD analysis, showed significant improvements in wall deformation and equivalent 
stresses in proposed designs. 
For evaluation of the deformations and equivalent stresses in Chapter 5, more sophisticated 
material models that account for anisotropy and non-linearity of the material can be utilised. 
Deformation of the walls can be taken into account by employing two-way FSI analysis instead 
of one-way structural analysis performed in this study. However, it should be noted that two-
way FSI analysis is more important for simulations of more deformable structures, such as 
valves. The deformation of the conduit wall is relatively small, hence, FSI analysis is not 
critical for conduit geometry studies without a valve. 
Lastly, addressing the ultimate goal of the research group, more investigation on the material 
biocompatibility, material physical characteristics relevant to specific age groups, valve design 
and the possibility of 3D printing for manufacture will be required.   
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Appendix A 
The following MATLAB code was used to obtain a smooth approximation of the velocity that 
can be utilised as inlet boundary condition.  
syms n t 
% Defining the the triangular velocity 
T0=Period; 
Endtime=4*T0; 
w0=2*pi/T0; 
d1=Time interval 1 (d1 in Figure 3.8); 
d2=Time interval 2 (d2 in Figure 3.8); 
d3=Time interval 3 (d3 in Figure 3.8); 
d4=Time interval 4 (d4 in Figure 3.8); 
vpos=Peak positive velocity; 
vneg=Peak negative velocity; 
n=1:6; 
%Caluculating the Fourier series 
a0=(1/T0)*(int((vpos/d1)*t,t,0,d1) + int(vpos-(vpos/d2)*(t-d1), t, d1, (d1+d2)) + 
int((vneg/d3)*(t-(d1+d2)), t, (d1+d2), (d1+d2+d3)) + int(vneg-(vneg/d3)*(t (d1+d2+d3)), t, 
(d1+d2+d3), (d1+d2+d3+d4)));  
 
an=(2/T0)*(int((vpos/d1)*t*cos(n*w0*t),t,0,d1) + int((vpos-(vpos/d2)*(t-d1))*cos(n*w0*t), 
t, d1, (d1+d2)) + int((vneg/d3)*(t-(d1+d2))*cos(n*w0*t), t, (d1+d2), (d1+d2+d3)) + 
int((vneg-(vneg/d3)*(t-(d1+d2+d3)))*cos(n*w0*t), t, (d1+d2+d3), (d1+d2+d3+d4)));  
 
bn=(2/T0)*(int((vpos/d1)*t*sin(n*w0*t),t,0,d1) + int((vpos-(vpos/d2)*(t-d1))*sin(n*w0*t), t, 
d1, (d1+d2)) + int((vneg/d3)*(t-(d1+d2))*sin(n*w0*t), t, (d1+d2), (d1+d2+d3)) + int((vneg-
(vneg/d3)*(t-(d1+d2+d3)))*sin(n*w0*t), t, (d1+d2+d3), (d1+d2+d3+d4)));  
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%Plotting 
figure; 
xlabel('Time (s)', 'Fontsize', 14 ) 
ylabel('Velocity (m/s)', 'Fontsize', 14) 
x=0 : 0.01 :Endtime; 
f = @(x) [(vpos/d1)*x.*(0<=x & x<=d1) + (vpos-(vpos/d2)*(x-d1)).*(d1<x & x<=(d1+d2)) + 
(vneg/d3)*(x-(d1+d2)).*((d1+d2)<x & x<=(d1+d2+d3)) + (vneg-(vneg/d4)*(x-
(d1+d2+d3))).*((d1+d2+d3)<x & x<=(d1+d2+d3+d4))]; 
pf= @(x) [f(mod(x,T0))]; 
line(x,pf(x),'color','b', 'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0), 'color', 'g', 'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0) + an(2)*cos(2*x*2*pi/T0) + 
bn(2)*sin(2*x*2*pi/T0), 'color', 'm', 'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0) + an(2)*cos(2*x*2*pi/T0) + 
bn(2)*sin(2*x*2*pi/T0) + an(3)*cos(3*x*2*pi/T0) + bn(3)*sin(3*x*2*pi/T0), 'color', 'k', 
'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0) + an(2)*cos(2*x*2*pi/T0) + 
bn(2)*sin(2*x*2*pi/T0) + an(3)*cos(3*x*2*pi/T0) + bn(3)*sin(3*x*2*pi/T0) +  
an(4)*cos(4*x*2*pi/T0) + bn(4)*sin(4*x*2*pi/T0), 'color', 'r', 'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0) + an(2)*cos(2*x*2*pi/T0) + 
bn(2)*sin(2*x*2*pi/T0) + an(3)*cos(3*x*2*pi/T0) + bn(3)*sin(3*x*2*pi/T0) + 
an(4)*cos(4*x*2*pi/T0) + bn(4)*sin(4*x*2*pi/T0) + an(5)*cos(5*x*2*pi/T0) + 
bn(5)*sin(5*x*2*pi/T0), 'color', 'y', 'linewidth', 0.5) 
line(x, a0 + an(1)*cos(x*2*pi/T0) + bn(1)*sin(x*2*pi/T0) + an(2)*cos(2*x*2*pi/T0) + 
bn(2)*sin(2*x*2*pi/T0) + an(3)*cos(3*x*2*pi/T0) + bn(3)*sin(3*x*2*pi/T0) + 
an(4)*cos(4*x*2*pi/T0) + bn(4)*sin(4*x*2*pi/T0) + an(5)*cos(5*x*2*pi/T0) + 
bn(5)*sin(5*x*2*pi/T0) + an(6)*cos(6*x*2*pi/T0) + bn(6)*sin(6*x*2*pi/T0), 'color', 'c',  
'linewidth', 0.5) 
xlim([0, Endtime]) 
legend({'Triangular wave', 'Fourier n=1', 'Fourier n=2', 'Fourier n=3', 'Fourier 
n=4'},'Fontsize', 12 ) 
grid on 
legend()  
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Appendix B 
The calculation of the energy dissipation via the mechanical energy equation is described in 
this Appendix. To this end, starting from the differential form of the conservation of 
momentum equation 
Equation C.1: 𝜕𝜕𝜌𝜌𝒖𝒖
𝜕𝜕𝐸𝐸
+ ∇ ∙ (𝜌𝜌𝒖𝒖⊗ 𝒖𝒖) = −∇𝑝𝑝 + ∇ ∙ 𝛕𝛕 + ρ𝐠𝐠 
and taking the dot product with the velocity vector 𝒖𝒖, an equation for conservation of 
mechanical energy was obtained: 
Equation C.2: 𝒖𝒖 ∙ �𝜕𝜕𝜌𝜌𝒖𝒖
𝜕𝜕𝐸𝐸
+ ∇ ∙ (𝜌𝜌𝒖𝒖⊗ 𝒖𝒖) = −∇𝑝𝑝 + ∇ ∙ 𝛕𝛕 + ρ𝐠𝐠� 
This can be simplified to 
Equation C.3: 
𝜕𝜕
1
2
𝜌𝜌𝜌𝜌2
𝜕𝜕𝐸𝐸
+ ∇ ∙ �𝜌𝜌𝒖𝒖 1
2
𝑢𝑢2� = −𝒖𝒖 ∙ ∇𝑝𝑝 + 𝒖𝒖 ∙ ∇ ∙ 𝛕𝛕 + ρ𝒖𝒖 ∙ 𝐠𝐠 
By manipulating the stress and pressure terms, equations 4.7 and 4.8 are acquired 
Equation C.4: 𝒖𝒖 ∙ ∇𝑝𝑝 = ∇ ∙ (𝑝𝑝𝒖𝒖) − 𝑝𝑝∇ ∙ 𝒖𝒖 
Equation C.5: 𝒖𝒖 ∙ ∇ ∙ 𝛕𝛕 = ∇ ∙ (𝛕𝛕𝒖𝒖) − 𝛕𝛕 ∶ ∇𝒖𝒖 
If Φ𝐴𝐴 is defined as 𝛕𝛕 ∶ 𝛁𝛁𝒖𝒖, using equation 4.6-4.8 results in 
Equation C.6: 
𝜕𝜕
1
2
𝜌𝜌𝜌𝜌2
𝜕𝜕𝐸𝐸
+ ∇ ∙ �𝜌𝜌𝒖𝒖 1
2
𝑢𝑢2� = −(∇ ∙ (𝑝𝑝𝒖𝒖) − 𝑝𝑝∇ ∙ 𝒖𝒖) + ∇ ∙ (𝛕𝛕𝒖𝒖) −Φ𝐴𝐴 + ρ𝒖𝒖 ∙ 𝐠𝐠 
The viscous energy dissipation in Cartesian form is given by 
Equation C.7: Φ𝐴𝐴 = 2𝜇𝜇 ��𝜕𝜕𝜌𝜌𝑥𝑥𝜕𝜕𝜕𝜕 �2 + �𝜕𝜕𝜌𝜌𝑦𝑦𝜕𝜕𝜕𝜕 �2 + �𝜕𝜕𝜌𝜌𝑧𝑧𝜕𝜕𝜕𝜕 �2� + ��𝜕𝜕𝜌𝜌𝑦𝑦𝜕𝜕𝜕𝜕 � + �𝜕𝜕𝜌𝜌𝑥𝑥𝜕𝜕𝜕𝜕 ��2 + ��𝜕𝜕𝜌𝜌𝑧𝑧𝜕𝜕𝜕𝜕 �+ �𝜕𝜕𝜌𝜌𝑦𝑦𝜕𝜕𝜕𝜕 ��2 + ��𝜕𝜕𝜌𝜌𝑥𝑥𝜕𝜕𝜕𝜕 �+ �𝜕𝜕𝜌𝜌𝑧𝑧𝜕𝜕𝜕𝜕 ��2 
Integration of the mechanical energy conservation equation over the fluid volume and 
assuming incompressible flow in the absence of gravity gives 
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Equation C.8: 𝑑𝑑
𝑑𝑑𝐸𝐸
∫
1
2
𝜌𝜌𝑢𝑢2𝑑𝑑𝑉𝑉
 
𝑉𝑉𝑐𝑐(𝐸𝐸) + ∫ 12 𝜌𝜌𝑢𝑢2(𝒖𝒖 ∙ 𝒏𝒏) 𝑑𝑑𝑊𝑊 𝑊𝑊𝑐𝑐(𝐸𝐸) = 
� (−𝑝𝑝𝒏𝒏) ∙ 𝒖𝒖 𝑑𝑑𝑊𝑊 
𝑊𝑊𝑐𝑐(𝐸𝐸) + � (𝛕𝛕 ∙ 𝒏𝒏) ∙ 𝒖𝒖 𝑑𝑑𝑊𝑊 𝑊𝑊𝑐𝑐(𝐸𝐸) −� Φ𝐴𝐴 𝑑𝑑𝑉𝑉 𝑉𝑉𝑐𝑐(𝐸𝐸)  
Assuming the flow domain is unchanging with time and has constant volume of V, time 
integrating these equations over a complete oscillatory cycle of duration 𝑇𝑇 to obtain the total 
energy dissipation per cycle 
Equation C.9: ∫ ∫ Φ𝐴𝐴
 
𝑉𝑉
 𝑑𝑑𝑉𝑉𝑑𝑑𝑑𝑑𝑇𝑇
0
= −�∫ 1
2
𝜌𝜌𝑢𝑢2𝑑𝑑𝑉𝑉
 
𝑉𝑉
�
0
𝑇𝑇 + ∫ ∫ (𝛕𝛕 ∙ 𝒏𝒏) ∙ 𝒖𝒖 𝑑𝑑𝑊𝑊 𝑊𝑊𝑐𝑐(𝐸𝐸)𝑇𝑇0 − 
� �𝑝𝑝(𝒏𝒏.𝒖𝒖) 𝑑𝑑𝑊𝑊 
𝐴𝐴
𝑇𝑇
0
− � �
12𝜌𝜌𝑢𝑢2(𝒖𝒖 ∙ 𝒏𝒏) 𝑑𝑑𝑊𝑊 𝑊𝑊𝑐𝑐(𝐸𝐸)𝑇𝑇0  
Given a periodic velocity profile is being introduced the first two terms on the right-hand side 
must be zero, so the total energy dissipation is obtained by integrating the other two terms over 
a cardiac cycle. These terms can be defined in the CFD setup and will be explicitly evaluated 
in simulations and no approximation is required. 
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Appendix C 
In this Appendix Effective WSS and energy dissipation introduced in Section 3.7 are used to 
benchmark the performance of the modified geometries against a straight pipe. To this end, the 
abovementioned parameters were evaluated using the velocity data of each patient with three 
straight pipes as described below, and their values were compared with the values obtained for 
modified geometries. 
The minimum distance between inlet and outlet of the conduit, which is the minimum distance 
between right ventricle to pulmonary artery, was measured and set for the length of the first 
straight pipe. However, the minimum distance is not practically feasible, since it passes through 
the heart. Hence, a second straight pipe with the length equal to the length of the centreline of 
the modified conduit was proposed, this is a more realistic model.  
Also, through the study, it was found that longer lengths result in a small increase in energy 
dissipation, but a larger decrease in WSS. Hence, it was concluded that with the same diameter, 
the conduit with the longer length, will have a better overall performance. With this in mind, 
the last straight pipe was characterised with the higher length (length of centreline of the 
modified geometry) and the maximum diameter of 22 mm (as mentioned before, this is the 
maximum diameter that is clinically feasible).  
From the results shown in Table B.1 it can be seen that the diameter of the conduit has a 
significant effect on its performance. Increasing the diameter remarkably reduces WSS and 
energy dissipation. However, there are two main criteria that limit the size of the conduit: one 
is the ability of the body to accommodate the conduit, and the other is pulmonary edema. Too 
large conduit can result in pulmonary edema, which is a condition caused by excess fluid in 
the lungs. The fluid accumulates in several air sacs in the lungs and lead to difficulty in 
breathing. This situation can be fatal if medical attention is not sought. Thus, although from a 
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computational perspective, larger diameters are more appealing, clinical considerations made 
in Section 3.3 lead to a more suitable size. In brief, the second straight pipe is the most realistic 
and the third will have the minimum WSS and energy dissipation.  
In cases where a large decrease in WSS and energy dissipation through the straight pipe 
compared with the modified geometry is noticed, running the simulations with an upsized 
modified conduit is suggested. The results can be shared with clinicians and they can decide if 
the improvement in the performance is worth the risks an oversized conduit may bring about. 
Table C.1 Comparison of the performance of the straight pipe models with the modified geometries for 
all patients. 
 Model Length 
(mm) 
Diameter 
(mm) 
Change in  
𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄𝐄 𝐖𝐖𝐖𝐖𝐖𝐖 (%) Change in energy dissipation (%) 
Patient A Pipe 1 50 22 -14 57 
Pipe 2 66 22 -19 61 
Patient B Pipe 1 25 19 2 -36 
Pipe 2 43 19 -8 -32 
Pipe 3 43 22 -36 -60 
Patient C Pipe 1 20 22 12 12 
Pipe 2 30 22 2 16 
Patient D Pipe 1 20 18 7 -20 
Pipe 2 40 18 -6 -15 
Pipe 3 40 22 -42 -61 
Patient E Pipe 1 20 18 7 -20 
Pipe 2 40 18 -6 -15 
Pipe 3 40 22 -42 -61 
Patient F Pipe 1 50 17 -23 -47 
Pipe 2 80 17 -27 -43 
Pipe 3 80 22 -57 -80 
 
